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In 1825, Jean Marc Itard, chief physician at l’Institution Royale des Sourds-muets in 
Paris, published the story of the twenty-six-year old marquise de Dampierre, who ‘in 
the midst of a conversation that interests her extremely, all of a sudden, without being 
able to prevent it, interrupts what she is saying or what she is listening to with bizarre 
shouts and with words that are even more extraordinary and which make a deplorable 
contrast with her intellect and her distinguished manners’.
1
 Sixty years after this 
publication Georges Gilles de la Tourette, a young neurologist working under the 
supervision of Jean Martin Charcot at the Salpêtrière Hospital in Paris, borrowed 
Itard’s case of the marquise for his study on the disorder he named ‘maladie des tics’.
2
 
Charcot preferred the eponym of "Gilles de la Tourette" and attached this name to the 
disorder. 
Of the nine patients with bizarre movements and utterances described in Gilles de 
la Tourette’s study, only the marquise would be classified as having Tourette’s disorder 
according to the criteria of the contemporarily used Diagnostic and Statistical Manual 
of Mental Disorders fourth edition, text revised (DSM-IV-TR)
3
: presence of multiple 
motor tics and minimally one vocal tic, lasting at least one year. The DSM-IV-TR also 
describes criteria for other tic disorders, such as chronic motor and vocal tic disorders, 
and transient tic disorder, and defines tics as sudden, rapid, recurrent, nonrhythmic 
movements (i.e., motor tics) and utterances (i.e., vocal tics) that typically mimic some 
aspect or fragment of normal behavior. Any voluntary movement and vocalization can 
emerge as a tic and therefore the list of possible tics is limitless. Most people associate 
Tourette’s disorder with coprolalia (i.e., the involuntary utterance of obscene words or 
socially inappropriate remarks), but only about 10% of patients with Tourette’s 
disorder suffer from this symptom.
4
 Although tics can be handicapping, they often 
cause no hinder. However, the presence of a wide range of comorbid psychiatric 
conditions and symptoms in patients with a tic disorder is rather the rule than the 














, and autism spectrum disorder (ASD)
6,9
 have been reported in patients with 
tics. Although clinically and epidemiologically related, the underlying etiological 
relations between tic disorders and these comorbidities are still under debate. Tics and 
comorbid disorders may have independent etiologies, as has been suggested especially 
regarding depressive and anxiety disorders
10
, but also with regard to ADHD.
11
 OCD and 
ASD may have shared etiologies with tic disorders
9,12
, whereas patients with tics as 
well as ADHD and OCD, may represent a separate nosological entity.
11
 However, most 




 GENERAL INTRODUCTION 
Pathogenesis of tic disorders 
With the appearance of Freudian psychiatry in the early twentieth century, tic 
disorders shifted out of neurology largely into psychiatry where tics were thought to 
be expressions of emotional disturbances. In 1921, the first purely psychoanalytic 
explanation of tic disorders was proposed by the Hungarian psychoanalyst Sandor 
Ferenczi who considered tics as a symbolic expression of masturbation.
13
 The discovery 
of the efficacy of neuroleptic drugs in patients with a tic disorder led towards the 
conceptualization of tics as neurological phenomena in the mid-1960s. Nearly fifty 
years later the exact etiological mechanisms of tic disorders still remain elusive. 
Family and twin studies have provided strong evidence for a genetic basis; 
however, no independently replicated genes have been identified yet.
12
 Serotonergic 
and dopaminergic genes are likely involved in the phenotypic expression of tic 
disorders, given that biochemical and pharmacological studies have indicated a 
substantial contribution of the serotonin and dopamine systems in the etiology of 
tics.
14-16
 A wealth of studies has investigated variable regions of these genes in patients 
with tic disorders and/or co-occurring conditions, but shown inconclusive results.
17-24
 
Susceptibility genes involved in tic disorders may be difficult to identify because of 
a complex mode of inheritance, comprising several genes that each have only a small 
effect. Moreover, the clinical heterogeneity of tic disorders, including the presence of 
co-occurring symptoms and disorders, may hinder the progression of genetic research. 
Finally, environmental factors, such as perinatal adversities and infections, may 
modulate or interact with the gene effect, further complicating the search for genes. 
The involvement of gene-environment interactions in the pathogenesis of tic disorders 
had been assumed 20 years ago
25
, but has yet received little research attention. 
Already in 1956 Pasamanick et al.
26
 investigated perinatal adverse events in 
children with tics, and demonstrated that the mothers of children with tics had had 
more pregnancy and delivery complications than the mothers of healthy children. In 
general, later studies have confirmed this finding suggesting that perinatal adversities, 
specifically pregnancy and delivery complications
25
, and prenatal smoking exposure
27
, 
may be associated with presence and severity of tics. With regard to comorbid 
conditions in children with tic disorders, few studies have been performed: delivery 
complications and prenatal exposure to smoking, coffee, or alcohol may form risk 
factors for OCD
27,28




Infections and the immune system have also been suggested to contribute to tic 
disorders. In 1998 Swedo et al. proposed a putative subgroup of neuropsychiatric 
disorders, designated as pediatric autoimmune neuropsychiatric disorders associated 
with streptococcal infections (PANDAS) characterized by the sudden onset and/or 
symptom exacerbations of OCD and/or tic disorder which are temporally related to 
group A ß-hemolytic streptococcal (GABHS) infections.
30
 Introduction of the still 
controversial concept of PANDAS has greatly fuelled research on the role of immunity 
1 
11 
 in tic disorders and is roughly based on three possible pathways: involvement of 
autoimmune responses, altered (cellular) immunity, and/or compromised immune 
system leading to an increased vulnerability to infections.  
Most studies have used Sydenham’s chorea (an autoimmune sequel of post 
streptococcal acute rheumatic fever) as a pathogenetic model: neuronal and 
streptococcal epitopes show molecular mimicry, and therefore anti-streptococcal 
antibodies may cross-react with neuronal tissue. Presence of anti-neuronal 
antibodies
31-33
, decreased numbers of regulatory T cells (Treg) that maintain tolerance 
to self antigens
34
, increased single time point serum levels of antistreptococcal 
antibodies
32,35,36
, and identification of candidate auto-antigens
37-39
 in patients with a tic 
disorder hint at autoimmunity being involved in the etiology of tics, although not all of 
these findings could be confirmed.
40-42
  
Few studies have assessed general immune markers in patients with tics and 
demonstrated higher serum levels of cytokines interleukin (IL)-12 and tumor necrosis 
factor-α in patients with Tourette’s disorder and/or OCD
43
, elevated plasma IL-12 
levels in patients with Tourette’s disorder as well as comorbid OCD
44
, and increased 
serum levels of soluble adhesion molecules E-selectin and vascular cell adhesion 
molecule-1 in patients with Tourette´s disorder.
45
 
Most recently, a new point of view has entered immunological research regarding 
tic disorders. Patients with tics may exhibit a compromised ability to clear microbial 
pathogens as has been suggested by the findings that patients with a newly diagnosed 
tic disorder or OCD were more likely to have had a GABHS infection in the previous 
year.
46,47
 A higher vulnerability to infections may be caused by lower immunoglobulin 




Scope of this thesis 
Although a wide spectrum of neurobiological factors that possibly contribute to the 
development of tics and associated disorders has been studied, the exact pathogenesis 
is still unknown. This thesis describes studies on possible neurobiological involvement 
in tic disorders and comorbid symptoms. We have aimed to study possible associations 
between severity of tics and co-occurring features and perinatal adversities (chapter 
2), and polymorphisms of serotonergic and dopaminergic genes, both separately as 
well as in interaction with perinatal adversities (chapters 3, 4, and 5), and to clarify the 
possible role of the immune system (chapters 6 and 7) in patients with a tic disorder. 
Chapters 2, 3, 4, and 5 report on possible associations between perinatal 
adversities and severity of tics and co-occurring symptoms in patients with a tic 
disorder. Presence of pregnancy complications relates to increased tic severity but 
decreased OCD symptoms, presence of delivery complications to increased severity of 
tics and ADHD symptoms, and prenatal smoking exposure to more severe comorbid 




described in chapter 2 provides indirect evidence of gene-environment interactions, 
comprising a positive family history of mental disorders as a proxy for DNA and 
presence of smoking exposure in utero, contributing to the severity of comorbid ADHD 
features. Three molecular genetic studies (chapters 3, 4, and 5) follow that investigate 
possible associations between polymorphisms of solute carrier family 6, member 4 
(SLC6A4), monoamine oxidase (MAO) A, dopamine receptor (DR) D4, and SLC6A3 
genes and severity of tics and comorbid symptoms. We address both main effects of 
these polymorphisms as well as possible interactions with perinatal adversities. 
Chapter 3 describes relations between the SLC6A4 gene and increased severity of tics 
and comorbid ADHD, OCD, and ASD symptoms in children and adolescents with tics, as 
well as between the MAOA gene and decreased severity of ASD features. Moreover, 
the MAOA gene interacts with perinatal adversities to modulate tic severity. In chapter 
4, we report on a contribution of the DRD4 gene to severity of comorbid OCD and ASD 
symptoms in children and adolescents with a tic disorder. The DRD4 gene also 
interacts with delivery complications regarding severity of tics and co-occurring 
internalizing symptoms. Chapter 5 demonstrates a relation between the SLC6A3 gene 
and severity of inattentive symptoms in patients with a tic disorder. Interactions 
between the SLC6A3 gene and pregnancy complications are associated to severity of 
obsessions and compulsions. In Chapter 6 results of a study on general markers of 
immunity are described. Children and adolescents with tics cannot be distinguished 
from healthy subjects based on serum levels of several cytokines and soluble adhesion 
molecules. However, serum IL-2 levels are associated with tic severity, and serum IL-12 
levels inversely related to severity of OCD symptoms. In chapter 7, we describe Ig 
profiles of children and adolescents with a tic disorder and healthy volunteers. Serum 
levels of IgM and IgG3 are decreased in patients compared to healthy children and of 
IgG1 (trend-level significantly) elevated during tic exacerbations. 
In chapter 8, our overall results are discussed. Future investigations and concluding 
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Objective To investigate the role of perinatal adversities with regard to tic severity and 
comorbid attention deficit/hyperactivity disorder (ADHD) symptoms in children 
with a tic disorder.  
Methods In 75 children and adolescents with a tic disorder we retrospectively assessed 
presence of pregnancy, delivery, and postnatal complications, and of prenatal 
exposure to smoking and alcohol. Children with and without these perinatal 
adversities were compared regarding tic and ADHD symptom severity. 
Furthermore, through linear regressions we investigated whether perinatal 
adversities would interact with presence in first-degree relatives of tic or any 
mental disorders with the tic or ADHD measure as outcome. 
Results Presence of pregnancy and delivery complications was related to tic severity, 
and prenatal smoking exposure to severity of comorbid ADHD symptoms. The 
relationship between smoking exposure in utero and ADHD symptom severity 
appeared to be more pronounced in children with a positive family history of 
mental disorders.  
Conclusion This study provides evidence of a role for perinatal adversities in the 
etiology of tic disorders. Children with perinatal adversities may be vulnerable to 
develop more severe tics or comorbid ADHD symptoms in the presence of a 





Notwithstanding the unequivocal involvement of genetics
1
, environmental factors also 
play a role in the etiology of tic disorders.
2
 Specifically, perinatal adverse events have 




In general, perinatal adversities have been found to both form a risk factor for tic 
disorders as such and to be associated with increased tic severity. An early study
12
 
demonstrated that the mothers of children with tics (N = 51, all under 14 years of age) 
showed significantly more pregnancy and delivery complications than the mothers of 
healthy children (N = 51); later a study
3
, which involved seven pairs of monozygotic 
twins, reported that the co-twins with Tourette’s disorder (TD) had lower birth weights 
than the unaffected co-twins. Another study
5
, comparing 92 TD patients with 460 
healthy controls (age range 5 to 31 years), however, did not find a relationship 
between the presence of TD and prenatal complications, gestational age, birth weight, 
and Apgar scores. Also, Khalifa et al.
6
 reported no statistically significant differences 
between 25 children with TD and 25 healthy subjects (age range 7 to 15 years) with 
regard to reduced optimality of pregnancy, delivery, and the postnatal period, 
although the mothers of children with TD were two times more likely to have had 
pregnancy complications. 
Severity of tics has been found to be higher when mothers had suffered from stress 
and severe hyperemesis during pregnancy in a study involving 31 children with TD 
between 7 and 17 years.
7
 A twin study
8
 of 16 pairs of monozygotic twins in whom at 
least one twin had TD (age range 8 to 26 years), demonstrated an association between 
the intra-pair differences in birth weight and tic severity scores. Recently, a relation 
between tic severity and prenatal maternal smoking, but not birth weight and 
perinatal complications, has been demonstrated in 180 patients with TD (age range 3 
to 59) recruited for three genetic studies: a genetic study in Costa Rica (N = 53), a 
genetic study among individuals of Ashkenazi Jewish descent in the United States (N = 
99), and an affected sibling pair study in the United States (N = 28).
9
 
Three studies have investigated the role of perinatal adversities with regard to 
comorbid conditions in children with tic disorders.
9-11
 Presence of comorbid obsessive-
compulsive disorder (OCD) in 49 children with TD, aged 7 to 18 years, appeared to be 
associated with forceps delivery and prenatal exposure to smoking, coffee, or 
alcohol.
10
 Mathews et al.
9
 found evidence for a role of smoking exposure in utero in 
comorbid OCD, and an association of both birth weight and the number of prenatal 
problems with presence of comorbid attention deficit/hyperactivity disorder (ADHD) in 
children with TD; surprisingly, prenatal drug exposure was associated with a reduced 
risk of comorbid ADHD.
9
 A recent study
11
 demonstrated greater odds of comorbid 
ADHD in children with TD (N = 353, age range 5 to 17 years) who were born with a low 




In the present study, we investigated relations of perinatal adversities with severity 
of both tic and comorbid ADHD symptoms in children and adolescents with a tic 
disorder. We hypothesized that perinatal adversities would be related to increased 
severity of both tics and ADHD symptoms. We also investigated the role of perinatal 
adversities in interaction with a positive family history of both tic disorders as well as 
mental disorders in general, as a proxy for genetic vulnerability. We hypothesized that 
a positive family history of tic and mental disorders would interact with perinatal 
adversities to increase tic and ADHD symptom severity. The involvement of gene-
environment interactions in the pathogenesis of tic disorders had been hypothesized 
by Leckman and colleagues almost 20 years ago
7
, but has yet received little research 
attention. A recent study
9
, however, found no interactions between a positive family 
history of tic and OCD symptoms and perinatal adversities with regard to tic severity 
and presence of comorbid OCD and ADHD, but had not taken family history for mental 
disorders in general into account. 
Methods 
Study sample 
The study group involved all patients, aged 6 to 18 years, who had participated in an 
ongoing research project studying neuroimmunology and genetics of tic disorders. 
Children had been recruited through our outpatient child and adolescent psychiatry 
clinic or the Dutch TD Association and had to fulfill criteria of the Diagnostic and 
Statistical Manual of Mental Disorders fourth edition, text revised (DSM-IV-TR)
13
 for 
either TD, chronic motor tic disorder, or chronic vocal tic disorder. The study had been 
approved by our Institutional Review Board. Informed consent from parents and 




Parents were interviewed regarding their child’s tic severity by using the Yale Global 
Tic Severity Scale (YGTSS), both with regard to the current week and the week in which 
the tics were worst ever.
14
 The YGTSS is a semi-structured interview, which records the 
number, frequency, intensity, complexity, and interference of motor and vocal tics 
separately. The sum of both scores is used as a measure of total tic severity. 
 ADHD symptom severity was investigated by using the parent version of the ADHD 
rating scale.
15
 The ADHD rating scale is a DSM-IV based questionnaire containing 18 
items on inattentive and hyperactive-impulsive symptoms to be scored on a four-point 
scale (0 = never, 1 = sometimes, 2 = often, 3 = very often). 
Parents also completed questionnaires with regard to prenatal smoking and alcohol 
exposure as well as pregnancy, delivery, and first-week postnatal complications. We 
investigated prenatal smoking and alcohol exposure by asking the mother if she had 








Table 1  
Comparisons between patients with a tic disorder with and without a number of 






  present absent   present absent   
  n mean ± SD n mean ± SD t p n mean ± SD n mean ± SD t p 
Current  
YGTSS  
27  43    28  42    
motor  13.2 ± 4.8  11.7 ± 5.1 -1.25 .22  11.8 ± 5.7  12.6 ± 4.5 0.63 .53 
vocal  9.0 ± 6.1  5.6 ± 5.1 -2.52 .01  7.7 ± 6.0  6.4 ± 5.5 -0.92 .36 
total  22.3 ± 9.4  17.3 ± 8.4 -2.28 .03  19.5 ± 10.5  19.0 ± 8.4 -0.23 .82 
Worst ever 
YGTSS  
27  43    28  42    
motor  16.8 ± 4.3  15.8 ± 5.0 -0.84 .40  17.3 ± 4.6  15.5 ± 4.7 -1.63 .11 
vocal  9.2 ± 7.6  9.4 ± 6.5 0.07 .94  11.4 ± 7.5  7.9 ± 6.2 -2.12 .04 
total  26.0 ± 8.3  25.2 ± 8.6 -0.41 .68  28.7 ± 9.1  23.4 ± 7.3 -2.71 .01 
ADHD 
rating scale  
26  39    26  39    
hyperactive-
impulsive 
 9.1 ± 5.8  9.1 ± 6.9 0.01 .99  9.9 ± 6.0  8.6 ± 6.8 -0.81 .42 
inattentive  10.0 ± 4.7  12.1 ± 6.9 1.36 .18  13.0 ± 5.5  10.1 ± 6.4 -1.88 .07 
total  19.1 ± 9.2  21.2 ± 12.1 0.76 .45  22.9 ± 9.3  18.7 ± 11.9 -1.53 .13 
 First-week postnatal complications
c
 
  present absent   
  n mean ± SD n mean ± SD t p 
Current  
YGTSS  
18  51    
motor  12.5 ± 5.3  11.7 ± 4.11 0.61 .55 
vocal  7.3 ± 5.6  6.9 ± 5.8 -0.26 .80 
total  18.9 ± 8.8  19.4 ± 9.4 0.17 .87 
Worst ever 
YGTSS  
18  51    
motor  16.5 ± 4.5  16.3 ± 4.7 -0.16 .87 
vocal  8.6 ± 7.7  9.6 ± 6.7 0.51 .61 
total  25.1 ± 9.9  25.9 ± 7.9 0.33 .74 
ADHD 
rating scale  
17  47    
hyperactive-
impulsive 
 8.3 ± 6.3  9.5 ± 6.6 0.66 .51 
inattentive  12.7 ± 6.4  10.8 ± 6.1 -1.08 .28 
total  21.0 ± 9.8  20.3 ± 11.6 -0.22 .83 
 
YGTSS, Yale Global Tic Severity Scale; 




infections, (pre)ecclampsia, psychosocial 
stress, or diabetes mellitus. 
b
Including 
presence of meconium-stained amniotic 
fluid, premature rupture of the 
membranes, nuchal cord, fetal 











  Prenatal smoking exposure Prenatal alcohol exposure 
  present absent   present absent   
  n mean ± SD n mean ± SD t p n mean ± SD n mean ± SD t p 
Current  
YGTSS  
11  59    8  62    
motor  14.1 ± 4.3  12.0 ± 5.1 -1.31 .19  10.1 ± 5.6  12.6 ± 4.9 1.31 .20 
vocal  7.4 ± 7.3  6.9 ± 5.5 -0.26 .79  4.5 ± 5.1  7.2 ± 5.8 1.29 .20 
total  21.5 ± 10.5  18.8 ± 8.8 -0.88 .38  14.6 ± 9.6  19.8 ± 8.9 1.54 .13 
Worst ever 
YGTSS  
11  59    8  62    
motor  15.3 ± 3.5  16.4 ± 4.9 0.72 .47  15.0 ± 2.6  16.4 ± 4.9 0.77 .44 
vocal  9.8 ± 6.2  9.2 ± 7.1 -0.27 .79  5.9 ± 8.2  9.7 ± 6.7 1.50 .14 
total  25.1 ± 7.8  25.6 ± 8.6 0.18 .86  20.9 ± 10.1  26.1 ± 8.0 1.68 .10 
ADHD  
rating scale  
11  54    8  57    
hyperactive-
impulsive 
 11.4 ± 6.2  8.5 ± 6.4 -1.86 .07  8.0 ± 7.2  9.3 ± 6.4 0.52 .60 
inattentive  14.0 ± 5.5  10.7 ± 6.2 -1.65 .10  13.8 ± 5.8  10.9 ± 6.2 -1.24 .22 
total  26.4 ± 10.1  19.1 ± 10.9 -2.03 .05  21.8 ± 10.3  20.2 ± 11.2 -0.38 .71 
YGTSS, Yale Global Tic Severity Scale; ADHD, attention deficit/hyperactivity disorder. 
 
hypertension, infections, (pre)ecclampsia, psychosocial stress, or diabetes mellitus. 
Presence of meconium-stained amniotic fluid, premature rupture of the membranes, 
nuchal cord, fetal bradycardia, placenta praevia, or artificial delivery was classified as a 
delivery complication. Postnatal complications could include respiratory distress, 
hyperbilirubinemia, or hypothermia. 
Finally, we asked parents to indicate whether or not a tic disorder or any mental 
disorder was present in a first-degree relative of the child through the following 
questions: Does the child have a parent or a sibling with tics? Does the child have a 
parent or a sibling with any other mental illness? Because of small sample sizes, 
separate mental illnesses could not be used in the analyses. 
 
Statistical analyses 
We made comparisons between patients with and without at least one pregnancy 
complication, with and without a delivery complication, with and without a postnatal 
complication, with and without prenatal smoking exposure, and with and without 
prenatal alcohol exposure. We tested between-group differences by using Student’s t 
test regarding current and worst ever motor, vocal, and total YGTSS scores, and 




 Table 2 
Linear regression analysis for the hyperactive-impulsive ADHD rating scale score with 
regard to the interaction term of presence of first-degree relative with mental disorder 
and prenatal smoking exposure. 
Independent variable b SE β p 
Prenatal smoking exposure -3.00 3.6 -.17 .41 
Presence of first-degree relative with a mental disorder 2.98 1.8 .23 .10 
Interaction term of presence of first-degree relative with a mental 
disorder and prenatal smoking exposure 
9.88 4.6 .45 .04* 
ADHD, attention deficit/hyperactivity disorder. *Adjusted R² = .18 (F = 4.91, df = 3, 50, p < .01). 
 
Furthermore, those perinatal adversities that appeared to yield at least trend-level 
statistically significant (i.e. p ≤ .10) between-group differences with regard to a tic or  
ADHD measure were used as independent variable together with interaction terms of 
the perinatal adversity with positive first-degree family history for a tic disorder and 
any mental disorder, respectively, with the tic or ADHD measure as outcome. 
In all statistical analyses p ≤ .05 was considered as significant and tests were two-
sided. Given that we planned a total number of 45 between-group comparisons, the 
significance level corrected for the number of analyses would be 0.05 / 45 = 0.001. 
With regard to interaction terms, p-levels between .05 and .10 were regarded as 
indicating trend-level significance.  
Results 
The study involved 75 patients with a tic disorder (mean age 12.2 years [SD 3.3], 88.0% 
male). Most of the patients (n = 60) had been referred to our outpatient child and 
adolescent psychiatry clinic, the remaining (n = 15) were recruited through the Dutch 
TD Association. Patients fulfilled criteria for either TD (n = 62; 82.7%), chronic motor tic 
disorder (n = 12; 16.0%), or chronic vocal tic disorder (n = 1; 1.3%). At the time of 
investigation, psychotropic medication was used by 53% of patients (n = 40), either 
antipsychotic agents (n = 12), clonidine (n = 3), psychostimulants (n = 8), atomoxetine 
(n = 4), or a combination of two or more agents (n = 13). Mean current total, motor, 
and vocal YGTSS scores were 19.1 (SD 9.0, range 0 - 39), 12.3 (SD 4.9, range 0 - 22), and 
6.8 (SD 5.7, range 0 - 19), respectively; respective mean worst ever YGTSS scores were 
25.6 (SD 8.6, range 10 - 47), 16.3 (SD 4.7, range 0 - 25), and 9.3 (SD 7.0, range 0 - 23). 
Mean total, hyperactive-impulsive, and inattentive scores were 20.7 (SD 11.1, range 1 - 
43), 9.2 (SD 6.6, range 0 - 23), and 11.4 (SD 6.1, range 0 - 23), respectively. The 
questionnaire regarding perinatal adversities was available from 70 patients. Prenatal 
exposure to smoking occurred in 11 patients (15.7%); prenatal alcohol exposure in 8 
cases (11.4%); pregnancy complications in 27 patients (38.6%); delivery complications 
in 28 patients (40.0%); and postnatal complications in 18 patients (25.7%). Data 





relative of the child were available from 68 and 58 patients, respectively. A tic disorder 
in a first-degree relative was present in 21 patients (30.9%); any mental disorder in 24 
patients (41.4%).  
 Table 1 shows between-group comparisons regarding presence or absence of a 
number of perinatal factors with regard to YGTSS and ADHD rating scale scores. Of 
note, patients with one or more delivery complication had significantly higher mean 
worst ever vocal and total YGTSS scores than patients without any delivery 
complication; current vocal and total YGTSS scores were significantly higher in patients 
with one or more pregnancy complication. Furthermore, patients who had been 
exposed to smoking in utero had significantly higher mean total ADHD rating scale 
scores. None of the between-group differences met the stringent significance level 
after correction for multiple testing. 
Subsequently, those perinatal adversities that yielded at least trend-level 
statistically significant between-group differences with regard to a tic or ADHD  
measure were investigated in interaction with presence or absence of a tic disorder 
and any mental disorder in first-degree relatives. Table 2 shows the linear regression 
analysis for the hyperactive-impulsive subscale score of the ADHD rating scale 
including the interaction term of the presence of a first-degree relative with a mental 












































Figure. Role of prenatal smoking exposure regarding hyperactive-impulsive ADHD rating
scale scores in patients with and without a first-degree relative with a mental disorder.
positive first-degree family 
history for mental disorder
negative first-degree family 
history for mental disorder
ADHD, attention deficit/hyperactivity disorder.
2 
25 
 to the hyperactive-impulsive ADHD rating scale score. The figure graphically displays 
the direction of effect: in patients with a first-degree relative with a mental disorder, 
smoking exposure during pregnancy was associated with a higher hyperactive- 
impulsive score: 17.2 (SD 1.8) versus 10.3 (SD 6.5), t = -4.07, p < .01. In contrast, in 
patients without a first-degree relative with a mental disorder prenatal smoking 
exposure was not associated with a higher hyperactive-impulsive score: 4.3 (SD 2.5) 
versus 7.3 (SD 6.0), t = 0.85, p = .45. Furthermore, the interaction term of presence of a 
first-degree relative with a mental disorder and prenatal smoking exposure was at 
trend-level significance related to the total ADHD rating scale score (b = 13.80, SE 8.1, 
β = .37, p = .09); in patients with a first-degree relative with a mental disorder, smoking 
exposure during pregnancy was associated with a higher total ADHD rating score: 32.4 
(SD 5.9) versus 21.8 (SD 11.0), t = -2.05, p = .05. In contrast, in the group of patients 
without a first-degree relative with a mental disorder prenatal smoking exposure was 
not associated with a higher total ADHD rating score: 14.0 (SD 9.6) versus 17.2 (SD 
10.2), t = 0.52, p = .61. No other statistically significant interaction terms of perinatal 
adversities with a positive first-degree family history for a tic or any mental disorder in 
association with a tic or ADHD measure were present. 
Discussion 
The present study suggests differential influences of pregnancy and delivery 
complications and smoking exposure in utero in children with a tic disorder: presence 
of pregnancy and delivery complications was related to tic severity, and prenatal 
smoking exposure to severity of ADHD symptoms. Moreover, we found preliminary 
evidence for possible gene-environment interactions: the relationship between 
smoking exposure in utero and ADHD symptom severity appeared to be more 
pronounced in children with a positive family history of mental disorders. We found no 
associations, however, of alcohol exposure in utero or postnatal complications with tic 
and ADHD symptom severity. The results of our study are in remarkable contrast with 
the findings of Mathews et al.
9
 of an association of prenatal smoking exposure with 
increased tic severity, and no association of pregnancy and delivery complications with 
tic severity. While we have no direct explanation for this, it should be noted that, in 
contrast to our study that only involved children and adolescents, 28% of patients in 
the study of Mathews were adults with TD. Adults who continue to have tics may form 
a distinct subgroup in terms of clinical characteristics and etiology.
16
 
Our finding that current tic severity is related to pregnancy complications is in line 
with an earlier study of Leckman and colleagues.
7
 Leckman only regarded current tic 
severity rather than life-time worst ever tic severity. The use of worst ever tic severity 
may be a more representative measure of tic severity given the waxing and waning 
pattern of tics. The relation between delivery complications and worst ever tic severity 




Prenatal smoking exposure was related to comorbid ADHD symptom severity in the 
present study. This is in line with the findings of Pringsheim et al.
11
 who recently 
reported a strong association between prenatal exposure to smoking and presence of 
ADHD. These findings are, again, contrary to the study of Mathews
9
 who found that in 
utero drug exposure, including tobacco, was associated with a reduced risk of ADHD in 
patients with TD. In patients with ADHD as such, a wealth of studies have indicated an 
association between exposure to prenatal smoking and ADHD.
17,18
 Results from animal 




Our finding of no relations of postnatal complications with tic and ADHD symptoms 
severity is in line with several previous studies.
6,9,11
 Also, in concordance with a 
previous study
11
, prenatal alcohol exposure was not related to comorbid ADHD 
symptoms. To our knowledge no previous publications concerning in utero exposure to 
alcohol in relation to tic severity are available. 
Children who had been exposed to smoking during pregnancy had more severe 
ADHD symptoms if they had a positive family history for mental disorders, which 
suggests the presence of gene-environment interactions. In a recent cohort of 
preadolescents from the general population, interactions between a family history of 
externalizing behavior and maternal prenatal smoking have been reported.
20
 In the 
etiology of ADHD as such, evidence regarding a role of gene-environment (mainly 
prenatal smoking exposure) interactions has been increasing
17
: for example, children 
who had been exposed to prenatal smoking demonstrated more severe hyperactive-
impulsive symptoms if they had the dopamine transporter-1 10-repeat allele.
21
 
The effects of pregnancy and delivery complications and smoking exposure in utero 
may be understood through fetal hypoxia.
22
 The basal ganglia, which have been 
implicated in the etiology of tic disorders
2
, are particularly sensitive to hypoxia.
23
 
Pregnancy and delivery complications could result in damage of the basal ganglia in the 
course of acute metabolic insults, such as transient fetal hypoxia. Brake et al.
24
 suggest 
dopamine dysregulation in the nucleus accumbens after perinatal complications 
involving hypoxia. Because of the involvement of dopaminergic pathways in tic 
disorders, this is an intriguing finding.
2
 Whether pregnancy and delivery complications 
affect only a subgroup of, for example genetic vulnerable, patients with a tic disorder, 
should be investigated in future studies. 
Nicotine crosses the placenta and the human fetus is exposed to even higher 
nicotine concentrations than the smoking mother.
25
 Nicotine achieves its effects 
through nicotinic acetylcholine receptors (nAChRs). In the fetal brain, nAChRs are 
widely distributed and involved in the maturation of brain structures during 
development. Prenatal nicotine exposure can change the expression of nAChRs in the 
fetal brain possibly as a result of chronic hypoxia or the direct toxic effects of 
nicotine.
22,26
 Animal studies have shown that nicotine exposure results in modulation 
of the dopaminergic system, probably mediated by subunits of nAChRs.
27,28
 
Apart from the direct consequences of nicotine, associations between prenatal 
smoking exposure and psychiatric disorders may also be understood through factors 
2 
27 
 often found associated with smoking, such as low socioeconomic status and presence 
of psychiatric disorders in parents.
29
 However, several studies
11,18
 found that smoking 
during pregnancy increased the risk of ADHD, even after adjusting for these 
confounders. Therefore, even if we did not assess parents’ socioeconomic status, it is 
likely that it is the true effect of smoking itself rather than confounding factors that 
best explains our results. 
A number of limitations need to be acknowledged. First, the sample size of our 
study group is relatively small, and given the limited statistical power, none of our 
findings actually reached significance when taking multiple testing into account. Using 
a too stringent multiple testing correction method, however, increases the type II error 
rate leading to false negative findings. Thus, study findings need to be interpreted with 
caution and further research directed at replication of our findings and investigation of 
the underlying pathophysiological mechanisms is warranted. Another disadvantage of 
our study has been the retrospective collection of perinatal data as well as worst ever 
tic severity. It has been reported though that long-term maternal recall is accurate for 
many factors related to pregnancy and delivery.
30
 A further limitation is the use of 
psychotropic medication in 53% of the patients, which may have affected current tic 
and ADHD symptom severity. Worst ever tic severity, however, was typically in a time 
when children did not use psychotropic medication. Furthermore, we investigated 
family history by parent report and not through direct examination of relatives. A meta 
analysis
31
, however, has shown high reliability for data collected by using family 
history. Finally, we have not investigated the amount and duration of prenatal 
maternal smoking and alcohol use. Todd et al., however, have found that it is the 
presence of prenatal smoking rather than the number of cigarettes or trimester of 
exposure that is predictive of ADHD.
32
 
In conclusion, this study confirms the earlier findings regarding the relation 
between pregnancy and delivery complications and tic severity
7
, and underlines the 
importance of prenatal smoking exposure in comorbid ADHD symptoms in children 
with a tic disorder.
11
 However, we could not replicate the findings of a relationship 
between prenatal smoking exposure and tic severity.
9
 Future studies addressing gene-





1. Keen-Kim D, Freimer NB. Genetics and 
 epidemiology of Tourette syndrome. J Child 
 Neurol 2006;21:665-671 
2. Hoekstra PJ, Anderson GM, Limburg PC, et 
 al. Neurobiology and neuroimmunology of 
 Tourette's syndrome: an update. Cell Mol 
 Life Sci 2004;61:886-898 
3. Leckman JF, Price RA, Walkup JT, et al. 
 Nongenetic factors in Gilles de la Tourette's 
 syndrome. Arch Gen Psychiatry 1987;44:100 
4. Burd L, Severud R, Klug MG, et al. Prenatal 
 and perinatal risk factors for Tourette 
 disorder. J Perinat Med 1999;27:295-302 
5. Klug MG, Burd L, Kerbeshian J, et al. A 
 comparison of the effects of parental risk 
 markers on pre- and perinatal variables in 
 multiple patient cohorts with fetal alcohol 
 syndrome, autism, Tourette syndrome, and 
 sudden infant death syndrome: an 
 enviromic analysis. Neurotoxicol Teratol 
 2003;25:707-717 
6. Khalifa N, von Knorring AL. Tourette 
 syndrome and other tic disorders in a total 
 population of children: clinical assessment 
 and background. Acta Paediatr 2005;94: 
 1608-1614 
7. Leckman JF, Dolnansky ES, Hardin MT, et al. 
 Perinatal factors in the expression of 
 Tourette's syndrome: an exploratory study. J 
 Am Acad Child Adolesc Psychiatry 1990; 
 29:220-226 
8. Hyde TM, Aaronson BA, Randolph C, et al. 
 Relationship of birth weight to the 
 phenotypic expression of Gilles de la 
 Tourette's syndrome in monozygotic twins. 
 Neurology 1992;42:652-658 
9. Mathews CA, Bimson B, Lowe TL, et al. 
 Association between maternal smoking and 
 increased symptom severity in Tourette's 
 syndrome. Am J Psychiatry 2006;163:1066-
 1073 
10. Santangelo SL, Pauls DL, Goldstein JM, et al. 
 Tourette's syndrome: what are the 
 influences of gender and comorbid 
 obsessive-compulsive disorder? J Am Acad 
 Child Adolesc Psychiatry 1994;33:795-804 
11. Pringsheim T, Sandor P, Lang A, et al. 
 Prenatal and perinatal morbidity in children 
 with Tourette syndrome and attention-
 deficit hyperactivity  disorder. J Dev Behav 
 Pediatr 2009;30:115-121 
12. Pasamanick B, Kawi A. A study of the 
 association of prenatal and paranatal factors 
 with the development of tics in children; a 
 preliminary  investigation. J Pediatr 1956; 
 48:596-601 
13. American Psychiatric Association. 
 Diagnostic and Statistical Manual of Mental 
 Disorders, 4th edition, text revision (DSM-
 IV-TR). Washington, DC: American 
 Psychiatry Association; 2000 
14. Leckman JF, Riddle MA, Hardin MT, et al. 
 The Yale Global Tic Severity Scale: initial 
 testing of a clinician-rated scale of tic 
 severity. J Am Acad Child Adolesc Psychiatry 
 1989;28:566-573 
15. DuPaul GJ. ADHD Rating Scale-IV: Checklists, 
 Norms and Clinical Interpretation. New 
 York: Power, T. J., Anastopoulos, A. D., and 
 Reid, R.; 1998 
16. Bloch MH, Leckman JF, Zhu H, et al. Caudate 
 volumes in childhood predict symptom 
 severity in adults with Tourette syndrome. 
 Neurology 2005;65:1253-1258 
17. Banerjee TD, Middleton F, Faraone SV. 
 Environmental risk factors for attention-
 deficit hyperactivity disorder. Acta Paediatr 
 2007;96:1269-1274 
18. Linnet KM, Wisborg K, Obel C, et al. Smoking 
 during pregnancy and the risk for 
 hyperkinetic disorder in offspring. Pediatrics 
 2005;116:462-467 
19. Ajarem JS, Ahmad M. Prenatal nicotine 
 exposure modifies behavior of mice through 
 early development. Pharmacol Biochem 
 Behav 1998;59:313-318 
20. Buschgens CJ, Swinkels SH, van Aken MA, et 
 al. Externalizing behaviors in preadole-
 scents: familial risk to externalizing 
 behaviors, prenatal and perinatal risks, and 
 their interactions. Eur Child Adolesc 
 Psychiatry 2009;18:65-74 
21. Becker K, El Faddagh M, Schmidt MH, et al. 
 Interaction of dopamine transporter 
 genotype with prenatal smoke exposure on 
 ADHD symptoms. J Pediatr 2008;152:263-
 269 
22. Lv J, Mao C, Zhu L, et al. The effect of 
 prenatal nicotine on expression of nicotine 
 receptor subunits in the fetal brain. 
 Neurotoxicology 2008;29:722-726 
23. Pisani A, Bonsi P, Calabresi P.Calcium 
 signaling and neuronal vulnerability to 




 24. Brake WG, Sullivan RM, Gratton A. Perinatal 
 distress leads to lateralized medial 
 prefrontal cortical dopamine hypofunction 
 in adult rats. J Neurosci 2000;20:5538-5543 
25. Luck W, Nau H, Hansen R, et al. Extent of 
 nicotine and cotinine transfer to the human 
 fetus, placenta and amniotic fluid of 
 smoking mothers. Dev Pharmacol Ther 
 1985;8:384-395 
26. Hellstrom-Lindahl E, Seiger A, Kjaeldgaard A, 
 et al. Nicotine-induced alterations in the 
 expression of nicotinic receptors in primary 
 cultures from human prenatal brain. 
 Neuroscience 2001;105:527-534 
27. Marks MJ, Grady SR, Collins AC. 
 Downregulation of nicotinic receptor 
 function after chronic nicotine infusion. J 
 Pharmacol Exp Ther 1993;266:1268-1276 
28. Zoli M, Moretti M, Zanardi A, et al. 
 Identification of the nicotinic receptor 
 subtypes expressed on dopaminergic 
 terminals in the rat striatum. J Neurosci 
 2002;22:8785-8789 
29. Roza SJ, Verhulst FC, Jaddoe VW, et al. 
 Maternal smoking during pregnancy and 
 child behaviour problems: the Generation R 
 Study. Int J Epidemiol 2009;38:680-689 
30. Rice F, Lewis A, Harold G, et al. Agreement 
 between maternal report and antenatal 
 records for a range of pre and perinatal 
 factors: the influence of maternal and child 
 characteristics. Early Hum Dev 2007;83:497-
 504 
31. Hardt J, Franke P. Validity, reliability and 
 objectivity of the family history method in 
 psychiatry: a meta analysis. Eur Psychiatry 
 2007;22:49-58 
32. Todd RD, Neuman RJ. Gene-environment 
 interactions in the development of 
 combined type ADHD: evidence for a 
 synapse-based model. Am J Med Genet B 





















polymorphisms of SLC6A4 and 
MAOA genes and severity of tics 
and comorbid symptoms in 
children and adolescents 
with a tic disorder










Netty G.P. Bos-Veneman 

























































The present study investigates relations of genetic polymorphisms and perinatal 
factors with phenotypic expression of tic disorders, including severity of tics and 
comorbid symptoms. We genotyped 109 children with a tic disorder with regard to 
the 5-hydroxytryptamine transporter-linked polymorphic region (5HTTLPR) 
including rs25531, and the monoamine oxidase upstream variable number of 
tandem repeats (MAOA uVNTR), and assessed presence of pregnancy and delivery 
complications, and of prenatal smoking exposure by parent questionnaires. 
Children with and without a 5HTTLPR long (L)A allele, and males with and without a 
MAOA uVNTR high-activity allele were compared regarding severity of tics and 
comorbid symptoms of attention deficit/hyperactivity disorder (ADHD), obsessive-
compulsive disorder (OCD), and autism spectrum disorder (ASD). Through linear 
regressions, we investigated whether perinatal adversities would interact with 
presence of an LA or MAOA uVNTR high-activity allele with severity ratings of tics or 
comorbid symptoms as outcome. Presence of an LA allele was associated with 
increased severity of tics and of comorbid ADHD, OCD, and ASD symptoms. 
Presence of a MAOA uVNTR high-activity allele was associated with decreased ASD 
symptom severity. Delivery complications were associated with ADHD symptom 
severity, and prenatal smoking exposure with ADHD and ASD symptom severity. 
The relationship between delivery complications and tic severity appeared to be 
most pronounced in males without MAOA uVNTR high-activity allele. In conclusion, 
this study provides evidence for a contribution of 5HTTLPR and the MAOA uVNTR 
to severity of tic and comorbid symptoms and for an interaction between MAOA 




Tic disorders, like Tourette’s Disorder (TD), are childhood-onset neuropsychiatric 
conditions of largely unknown etiology. Genetic factors unequivocally contribute to the 
pathogenesis of tic disorders, although no independently replicated susceptibility 
genes have yet been identified.
1
 The search for genes in tic disorders may be 
complicated by environmental factors associated with tics, such as perinatal 
adversities
2,3
, that could modulate or interact with the effects of genes. Whereas many 
study have focussed on the identification of disease genes, in the current study we 
addressed possible relations of common genetic and perinatal factors with the 
phenotypic expression of tic disorders, i.e., severity of tics and comorbid symptoms. 
Although the defining feature of tic disorders is the presence of sudden, rapid, 
recurrent, nonrhythmic motor movements, and/or vocalizations, a wide range of 
psychiatric conditions and symptoms often co-occur.
4
 Attention deficit/hyperactivity 
disorder (ADHD) and obsessive-compulsive disorder (OCD) are highly comorbid with 
TD.
5
 Moreover, patients with tic disorders may be prone to have features of autism 
spectrum disorders (ASD).
5,6
 The possible etiological relationships between tic and 
comorbid OCD and ADHD have been studied extensively. ADHD and tic disorders 
appear to have independent etiologies, although a TD/OCD/ADHD subtype may exist 
representing a separate, more severe, nosological entity.
1,7
 Findings of increased risk of 
early onset OCD in relatives of probands with TD indicate that tic disorders and OCD 
may have a shared genetic vulnerability.
1
 Regarding ASD, a shared genetic etiology 
with tic disorders has been suggested.
6
 
Serotonergic genes may be involved in tic disorders and comorbid symptoms, given 
that they have been implicated not only in tic disorders
8







 Thereby, pharmacological studies have demonstrated a positive effect on tic 
severity of risperidone, a combined serotonin and dopamine blocking agent
12
, and 
findings of (123I)β-CIT single photon emission computed tomography studies in 
patients with TD have pointed to a dysfunction of serotonergic neurotransmission.
13
 
One gene of considerable interest is the solute carrier family 6, member 4, gene 
(SLC6A4, also named 5-hydroxytryptamine transporter [5HTT] or serotonine 
transporter gene), encoding the serotonine transporter that reuptakes serotonin from 
synaptic spaces. SLC6A4 contains a 44 base pairs (bp) functional polymorphism in the 
SLC6A4-linked polymorphic region, called 5HTTLPR, which modulates the 
transcriptional activity of SLC6A4.
14
 The repetitive region that comprises 5HTTLPR 
exhibits an additional functional A→G single nucleo]de polymorphism (SNP; rs25531) 
with the minor allele (G) almost always in phase with the long (L) 5HTTLPR allele.
15
 
Thus, 5HTTLPR is functionally triallelic: the LA allele is the actual high-expressing 
variant, leading to more efficient reuptake of serotonin, whereas the LG and short (S) 
alleles are low-expressing. Only one study has investigated genetic (but not triallelic) 
variation at 5HTTLPR in patients with tic disorders. Cavallini and colleagues
16
 compared 
52 patients with TD and 63 healthy subjects regarding 5HTTLPR, but found no 
3 
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significant associations. Studies addressing relationships between 5HTTLPR and 
psychiatric conditions as such have shown inconsistent results. Two meta-analyses 
have reported the L allele as risk allele for ADHD
9,17
, whereas another could not 
support this association.
18
 Regarding OCD, one meta-analysis that included case-
control studies has found a positive relation with S allele homozygosity and a negative 
association with heterozygosity at 5HTTLPR
19
; another found no relationship between 
5HTTLPR and OCD when including both case-control and family-based studies but did 
identify an association with the L allele when including only family-based studies.
10
 
One study that took rs25531 into account has reported that the LALA genotype was 
approximately twice as common in 169 adults with OCD than in 253 controls and, 
moreover, that the LA allele was excessively transmitted in 175 trios consisting of 
probands with OCD and their parents.
15
 However, an attempt to replicate this finding 
failed.
20
 Regarding autism, one meta-analysis
11
 has been published that reported 
preferential transmission of the S allele in family-based studies of United States mixed 
population samples, but no allelic distortion among European and Asian populations.  
The gene encoding monoamine oxidase (MAO) A may also be of interest in tic 
disorders given that MAOA enzymatically degrades biogenic amines including 
dopamine and serotonin.
21
 An upstream variable number of tandem repeats (uVNTR) 
functional polymorphism with 3, 3.5, 4, or 5 copies of the 30-bp repeat sequence 
affects the transcriptional activity of the MAOA gene: alleles with 3.5 or 4 repeats (R) 
are transcribed two to ten times more efficiently, resulting in an elevated MAOA 
activity compared to those with 3R or 5R.
22
 A family-based association study, involving 
110 patients with TD, has demonstrated excess transmission of high-activity alleles.
8
 
High-activity alleles have also been related to ADHD and OCD.
9,23
 The 3R allele has 
been associated with ASD symptoms in boys with autism
24
, but not to presence of 
autism in case-control and family-based studies.
25,26
 
In the current study, we examined relations of genetic variation at the 5HTTLPR 
locus (including rs25531) and the MAOA uVNTR, with severity of tics and comorbid 
ADHD, OCD, and ASD symptoms in children and adolescents with a tic disorder. To 
date, no studies have directly addressed the involvement of gene-environment 
interactions in children with tic disorders, but our group did find indirect, preliminary 
evidence: smoking exposure in utero interacted with presence of a positive family 
history of mental disorders to increase ADHD symptom severity in children with a tic 
disorder.
27
 This is the first molecular genetic study to investigate perinatal adversities 











The study involved 109 patients with a tic disorder between 6 and 18 years (mean age 
12.3 years [SD 3.0]; 81.7% male), of which 75 patients had previously participated in a 
study investigating perinatal adversities.
27
 Most of the patients (n = 85) had been 
referred to our outpatient child and adolescent psychiatry clinic, the remaining (n = 24) 
were recruited through the Dutch TD Association. Patients fulfilled criteria of the 
Diagnostic and Statistical Manual of Mental Disorders fourth edition, text revised 
(DSM-IV-TR)
28
 for either TD (n = 96), chronic motor tic disorder (n = 11), or chronic 
vocal tic disorder (n = 2). At the time of investigation, parents indicated their child’s 
use of psychotropic medication. Psychotropic medication was used by 60 patients, 
either an antipsychotic agent (n = 21), clonidine (n = 7), methylphenidate (n = 8), 
atomoxetine (n = 4), a selective serotonin reuptake inhibitor (n = 2), or a combination 
of two or more agents (n = 18). 
Informed consent from parents and children of 12 years or older, and assent from 
children between 6 and 12 years was obtained. The study had been approved by our 
Institutional Review Board. 
 
Clinical measures 
Parents were interviewed regarding their child’s tic severity, with regard to the week in 
which the tics were worst ever, by using the Yale Global Tic Severity Scale (YGTSS), a 
semi-structured interview which records the number, frequency, intensity, complexity, 
and interference of motor and vocal tics separately.
29
 In a subgroup of patients (n = 
38), worst ever tic severity had not been assessed; here, we used current tic severity 
ratings. Mean total, motor, and vocal YGTSS ratings were 23.1 (SD 9.5, range 4 - 47), 
14.4 (SD 5.5, range 0 - 25), and 8.7 (SD 6.6, range 0 - 23), respectively. 
ADHD symptom severity was measured by using the parent version of the ADHD 
rating scale (available from 66 patients), a DSM-IV based questionnaire containing 18 
items on inattentive and hyperactive-impulsive symptoms to be scored on a four-point 
scale.
30
 Respective mean total, hyperactive-impulsive, and inattentive scores were 20.2 
(SD 11.2, range 1 - 43), 8.8 (SD 6.7, range 0 - 23), and 11.2 (SD 6.0, range 0 - 22). 
The Children's Yale-Brown Obsessive-Compulsive Scale (CYBOCS), a semi-structured 
interview rating five items regarding current severity of obsessions and compulsions 
separately (i.e., time spent, interference, distress, resistance, and degree of control), 
was used to interview parents regarding their child’s obsessive-compulsive symptom 
severity (available from 106 patients).
31
 Mean total, obsessive, and compulsive CYBOCS 
ratings were 5.0 (SD 7.3, range 0 - 28), 1.8 (SD 3.9, range 0 - 16), and 3.2 (SD 4.6, range 
0 - 16), respectively. 
The parent version of the Children’s Social Behavior Questionnaire (CSBQ) was 
administered to investigate severity of ASD features (available from 108 patients).
32
 
The CSBQ contains 49 items to be scored on a three-point scale that refer to six 
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subscales: not tuned (i.e., not optimally tuned to the social situation; mean 9.0 [SD 6.1, 
range 0 - 29]), reduced social interest (mean 4.5 [SD 4.6, range 0 - 17]), orientation 
problems (i.e., orientation problems in time, place, or activity; mean 5.4 [SD 4.7, range 
0 - 23]), not understanding (i.e., difficulties in understanding of social information; 
mean 4.5 [SD 3.8, range 0 - 14]), resistance to changes (mean 2.3 [SD 4.5, range 0 - 
27]), and stereotyped behavior (mean 3.6 [SD 3.3, range 0 - 13]). The sum of the 
subscales can be used as a measure of total ASD symptom severity (mean 29.3 [SD 
19.0, range 1 - 88]). 
Parents also completed questionnaires with regard to pregnancy and delivery 
complications, and maternal prenatal smoking (available from 86 patients). Pregnancy 
complications could include hypertension, infections, (pre)ecclampsia, psychosocial 
stress, or diabetes mellitus, and were present in 38 patients. Presence of meconium-
stained amniotic fluid, premature rupture of the membranes, nuchal cord, fetal 
bradycardia, placenta praevia, or artificial delivery was classified as a delivery 




DNA was extracted from blood samples or buccal swabs (Cytobrush
®
) using a manual 
salting out procedure.
33
 The SLC6A4 and MAOA polymorphisms were genotyped in a 
quality-certified laboratory at the Department of Human Genetics of the Radboud 
University Medical Center in Nijmegen, the Netherlands. 
Genotyping of 5HTTLPR was done by simple sequence length analysis. Polymerase 
chain reaction (PCR) was performed using 50 ng genomic DNA, 0.5 μM fluorescently 
labelled forward (FAM-5’-GGCGTTGCCGCTCTGAATGC-3’) and reverse primer (5’-
GAGGGACTGAGCTGGACAACCAC-3’), 0.25 mM deoxyribonucleotide triphosphates 
(dNTPs), 1x PCR optimization buffer A (30 mM Tris-HCl pH 8.5, 7.5mM (NH4)2SO4, 0.75 
mM MgCl2), 10% dimethylsulfoxide (DMSO), and 0.4 U AmpliTaq Gold® DNA 
Polymerase (Applied Biosystems, Nieuwerkerk a/d IJssel, The Netherlands). Cycling 
conditions were 12 minutes at 95°C, 35 cycles of 1 minute at 94°C, 1 minute at the 
optimized annealing temperature (57.5°C), and 2 minutes at 72°C, then followed by an 
extra 10 minutes at 72°C. 
Genotyping of rs25531 was performed on a 7500 Fast Real-Time PCR System using 
10 ng of genomic DNA, 0.25 μl of a custom-made Taqman assay (forty times; Applied 
Biosystems) that includes a forward (CCCTCGCGGCATCCC) and reverse primer 
(ATGCTGGAAGGGCTGCA), and two fluorescently labelled probes (VIC-
CTGCACCCCCAGCAT, FAM-CTGCACCCCCGGCAT), 5 μl of Taqman Mastermix (twice; 
Applied Biosytems), and 3.75 μl of water. Genotypes were scored using the algorithm 
and software supplied by the manufacturer (Applied Biosystems). The assay was 
validated by digesting the SLC6A4 PCR product with MspI (New England Biolabs, 
Ipswich, USA) and separating restriction fragments of 340 bp, 130 bp, and 60 bp for 
the LA allele, of 175 bp, 165 bp, 130 bp, and 60 bp for the LG allele, and of 300 bp, 130 
bp, and 60 bp for the S allele, on a 2% agarose gel. 
3 
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 The MAOA uVNTR was genotyped 
after amplification from 50 ng genomic 
DNA in a volume of 10 μl with 1x PCR 
buffer II (Applied Biosystems), 0.25 mM 
dNTPs, 2.5 mM MgCl2, 10% DMSO, 0.4 U 
AmpliTaq Gold® DNA Polymerase 
(Applied Biosystems), and 0.5 μM 
fluorescently labelled forward (FAM-5’-
ACAGCCTGACCG TGGAGAAG-3’) and 
reverse primer (5’-
GAACGGACGCTCCATTCGGA). 
Generally, 3% blanks as well as 
duplicates between plates were taken 
along as quality controls during 
genotyping. Subsequent determination 
of the length of the 5HTTLPR and MAOA 
uVNTR alleles was performed by direct 
analysis on an automated capillary 
sequencer (ABI3730, Applied 
Biosystems) using standard conditions. 
Genotype and allele frequencies are 




Regarding 5HTTLPR, we made comparisons between patients with and without at least 
one LA allele. Because MAOA is X-chromosomally located and the study sample 
involved only twenty females, we compared males with a high-activity allele (4R) of the 
MAOA uVNTR with males with a low-activity allele (3R and 5R). We made comparisons 
between patients with and without at least one pregnancy complication, with and 
without at least one delivery complication, and with and without prenatal smoking 
exposure. We tested between-group differences by using Student’s t test regarding 
ratings of severity of tics and comorbid symptoms. 
Furthermore, those perinatal adversities, that appeared to yield between-group 
differences at a significance level of at least p ≤ .20 with regard to a tic or comorbid 
symptom severity measure were used in linear regression as independent variable 
together with interaction terms of the perinatal adversity and the presence of the risk 
allele (i.e., LA for 5HTTLPR and the high-activity allele for the MAOA uVNTR) with the tic 
or comorbid symptom severity measure as outcome. Those regression analyses 
demonstrating a statistically significant interaction term in association with a tic or 
comorbid symptom severity measure were subsequently adjusted for gender and age  
in case of interactions with 5HTTLPR, or for age in case of interactions with the MAOA 
uVNTR. 
Table 1  
Frequencies of 5HTTLPR genotypes and 
MAOA uVNTR alleles in our study group of 
patients with a tic disorder. 
  Genotypes n % 
5HTTLPR LALA 24 22.3 
  LAS 51 47.2 
  LALG 9 8.3 
  SS 18 16.7 
  SLG 5 4.6 
  LGLG 1 0.9 
  total 108 100 
 Alleles n % 
MAOA uVNTR  3R 25 29.1 
(males)  4R 60 69.8 
  5R 1 1.1 
  total 86 100  
5HTTLPR, 5-hydroxytryptamine transporter-linked 
polymorphic region; MAO, monoamine oxidase; 
uVNTR, upstream variable number of tandem 
repeats; L, long allele; S, short allele; R, repeats. 
3 
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In all statistical analyses p ≤ .05 was considered as significant and tests were two-
sided. Given that we planned a total number of 80 between-group comparisons, the 
significance level corrected for the number of analyses would be .05 / 80 = .0006. 
Results 
5HTTLPR 
Table 2 shows comparisons between patients with and without at least one LA allele 
with regard to tic and comorbid symptom severity measures. Of note, patients with an 
LA allele had significantly higher mean motor and total YGTSS, hyperactive-impulsive 
ADHD rating scale, obsessive, compulsive, and total CYBOCS, and not understanding 
Table 2 
Comparisons between patients with and without minimally one 5HTTLPR LA allele 
regarding severity of tics and comorbid symptoms. 
  LA No LA   
  n mean SD n mean SD t p 
YGTSS  85   23     
motor  15.2 5.5  12.0 4.4 -2.57 .01 
vocal  9.0 6.7  7.7 6.1 -0.89 .38 
total  24.2 9.3  19.6 9.3 -2.10 .04 
         
ADHD rating scale  52   13     
inattentive  11.6 5.9  9.7 6.7 -1.04 .30 
hyperactive-impulsive  9.7 6.6  5.8 6.3 -1.97 .05 
total  21.5 10.9  15.9 12.2 -1.61 .13 
         
CYBOCS 83   22     
obsessive  2.2 4.2  0.4 1.3 -3.34 .001 
compulsive  3.5 4.8  1.5 3.5 -2.03 .03 
total  5.8 7.8  1.9 4.3 -3.10 .003 
         
CSBQ 80   22     
not tuned  9.4 6.0  7.6 6.2 -1.24 .22 
reduced social interest  4.7 4.5  4.1 4.8 -0.46 .65 
orientation problems  5.5 4.6  5.3 5.1 -0.22 .83 
not understanding  4.8 4.1  3.4 2.1 -2.20 .03 
resistance to changes   2.3 4.3  2.6 5.6 0.28 .78 
stereotyped behavior  3.8 3.4  2.7 3.0 -1.39 .17 
total  30.5 19.5  25.9 17.0 -1.01 .32 
5HTTLPR, 5-hydroxytryptamine transporter-linked polymorphic region; L, long allele; YGTSS, Yale Global Tic 
Severity Scale; ADHD, Attention deficit/hyperactivity disorder; CYBOCS, Children's Yale-Brown Obsessive-
Compulsive Scale; CSBQ, Children’s Social Behavior Questionnaire. 
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 CSBQ ratings compared to patients without LA allele. We found no other statistically 
significant between-group comparisons regarding 5HTTLPR and any tic or comorbid 
symptom severity measure. None of the between-group differences met the stringent 
significance level after correction for multiple testing. 
 
MAOA uVNTR  
Table 3 shows between-group comparisons of male patients with a high- and a low-
activity allele regarding tic and comorbid symptom severity measures. Patients with a 
high-activity allele had significantly lower mean reduced social interest CSBQ ratings, 
but this difference did not meet the stringent significance level after correction for 
multiple testing. We found no other statistically significant between-group 
comparisons regarding the MAOA uVNTR and any tic or comorbid symptom severity 
measure. 
Table 3 
Comparisons between male patients with a high- and low-activity allele of the MAOA 
uVNTR regarding severity of tics and comorbid symptoms. 
  High-activity allele Low-activity allele   
  n mean SD n mean SD t p 
YGTSS  60   26     
motor  14.7 5.0  15.2 4.8 0.40 .69 
vocal  8.3 6.9  9.5 6.3 0.79 .43 
total  23.0 9.1  25.7 9.0 0.80 .43 
         
ADHD rating scale  40   18     
inattentive  11.0 6.3  11.6 6.1 0.36 .72 
hyperactive-impulsive  8.7 6.8  7.7 6.9 -0.53 .60 
total  20.2 11.3  19.3 12.0 -0.25 .80 
         
CYBOCS 58   26     
obsessive  1.6 3.8  1.9 3.9 0.31 .76 
compulsive  3.0 4.5  3.0 4.6 0.07 .95 
total  4.6 7.1  5.0 7.1 0.19 .85 
         
CSBQ 55   25     
not tuned  8.0 4.7  9.7 7.4 1.01 .32 
reduced social interest  3.9 4.0  6.8 5.4 2.20 .04 
orientation problems  4.7 3.7  5.5 5.2 0.81 .42 
not understanding  4.2 3.5  4.2 4.1 -0.02 .98 
resistance to changes   1.5 1.4  2.6 5.3 1.05 .30 
stereotyped behavior  3.3 3.1  3.6 3.1 0.41 .68 
total  25.8 14.5  31.5 21.3 1.41 .16 
MAO, monoamine oxidase; uVNTR, upstream variable number of tandem repeats; YGTSS, Yale Global Tic 
Severity Scale; ADHD, Attention deficit/hyperactivity disorder; CYBOCS, Children's Yale-Brown Obsessive-
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Perinatal adversities 
In line with our previous findings in mainly the same study sample
27
, patients who had 
been exposed to smoking in utero had higher mean total ADHD rating scale scores 
(26.6 [SD 10.6] versus 18.7 [SD 10.9], t = -2.11, p = .04). Moreover, presence of a 
delivery complication and of prenatal smoking exposure were associated with higher 
inattentive ADHD rating scale scores (13.4 [SD 5.6] versus 9.8 [SD 6.0], t = -2.21, p = 
.03; and 14.6 [SD 5.4] versus 10.3 [SD 6.0], t = -2.13, p = .04, respectively). Smoking 
exposure in utero was also associated with higher orientation problems CSBQ ratings 
(6.6 [SD 3.8] versus 4.4 [SD 3.8], t = -1.99, p = .05). No other statistically significant 
between-group comparisons regarding any perinatal adversity and any symptom 
severity measure were present. None of the between-group differences met the 
stringent significance level after correction for multiple testing. 
 
Gene-environment interactions 
The interaction term of delivery complications and the MAOA uVNTR high-activity 
allele was significantly related to mean motor YGTSS ratings (b = -7.41, SE 2.6, β = -.69, 
p = .006), also after adjusting for age (b = -7.88, SE 2.6, β = -.73, p = .004). The figure 
graphically displays the direction of effect: in male patients without a high-activity 
allele, delivery complications were associated with higher mean motor YGTSS ratings 
(20.5 [SD 2.9] versus 14.2 [SD 4.1], t = -3.39, p = .003), while in the group of patients 





























Figure. Role of delivery complications regarding motor YGTSS ratings in male patients 
with and without a high-activity allele of the monamine oxidase upstream variable 
number of tandem repeats.
No high-activity allele
High-activity allele
YGTTS, Yale Global Tic Severity Scale.
n = 6
n = 32
n = 14 n = 18
 YGTSS ratings (14.5 [SD 5.4] versus 15.6 [SD 4.4], t = 0.80, p = .43). No other statistically 
significant interaction terms of perinatal adversities with the 5HTTLPR LA allele or the 
MAOA uVNTR high-activity allele in association with a tic or comorbid symptom 
severity measure were present. 
Discussion 
The present study indicates influences of 5HTTLPR and the MAOA uVNTR on the 
severity of tics and comorbid symptoms in children with a tic disorder. Presence of at 
least one HTTLPR LA allele was related to increased severity of tics and comorbid 
ADHD, OCD, and ASD symptoms. Presence of a MAOA uVNTR high-activity allele was 
associated with decreased severity of comorbid ASD features.  
 No studies regarding the relation between triallelic 5HTTLPR and tic and comorbid 
disorders had been performed so far. When LG alleles remain unrecognized in SL and LL 
genotypes, the influence of 5HTTLPR on clinical phenotypes may be obscured. For 
example, a previous study
16
 did not take the functional triallelic variation of 5HTTLPR 
into account and could not demonstrate an association of 5HTTLPR genotype and TD 
or comorbid OCD. By considering triallelic 5HTTLPR, however, we did find relations 
with severity of tics and comorbid symptoms. Regarding OCD as such, three studies 
have investigated possible associations with 5HTTLPR, including rs25531, and results 
are in line with our findings of a relation between the presence of an LA allele and 
increased severity of OCD. Hu et al.
15
 have found associations of LA with OCD. Although 
a large case–control study could not replicate these findings
20
, the same authors
34
 in a 
subsequent study have provided evidence for an increased frequency of higher-
expressing alleles in patients with OCD compared to healthy controls, when taking 
another functional 5HTTLPR variant, named rs25532, along with rs25531 into account. 
The present finding of an inverse association between the MAOA high-activity 
alleles and severity of comorbid ASD features is consistent with a previous study 




Previously, we had already reported the association between prenatal smoking 
exposure and ADHD symptom severity in mainly the same cohort.
27
 The relations 
between delivery complications and ADHD symptoms, and between maternal smoking 
during pregnancy and ASD symptom severity are novel findings in this study sample. 
Evidence regarding a role of smoking exposure during pregnancy in the development 
of ASD features has been expanding.
35
 
Most interestingly, we found evidence for a gene-environment interaction: the 
relationship between delivery complications and tic severity appeared to be most 
pronounced in boys without a MAOA uVNTR high-activity allele. These boys had more 
severe tics if they were born after a complicated delivery. No other studies have 
addressed the involvement of interactions between the MAOA uVNTR and perinatal 
adversities in children with tic disorders. However, an increased risk of antisocial 
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features has been associated with genotypes comprising low-activity alleles in boys 
who had been exposed to smoking in utero.
36
 
The presently reported associations between 5HTTLPR as well as the MAOA uVNTR 
and severity of tics and comorbid ADHD, OCD, and ASD symptoms support the notion 
of serotonergic neurotransmission being involved in the phenotypic manifestation of 
tic disorders. Although serotonergic imbalance may contribute to the expression of tics 
and comorbid symptoms in a direct way, complex interactions exist between the 
serotonergic and the dopaminergic system.
12
 Thereby, the direct effect of MAOA on 
dopamine may be of great importance. 
A number of limitations need to be acknowledged. First, the sample size of our 
study group has been relatively small, and given the limited statistical power, none of 
our findings actually reached significance when taken multiple testing into account. 
Using a too stringent multiple testing correction method, however, increases the type 
II error rate, i.e., the risk of false negative findings. Clearly, study findings need to be 
interpreted with caution and further research directed at replication of our findings 
and investigation of the underlying pathophysiological mechanisms is warranted. 
Another disadvantage of our study has been the retrospective collection of worst ever 
tic severity. A further limitation is the use of psychotropic medication in 55% of the 
patients, which may have affected comorbid symptom severity. Worst ever tic 
severity, however, was typically in a time when children did not use psychotropic 
medication. Finally, other SNPs, for example rs25532, at the 5HTTLPR locus may also 
be involved, but have not been assessed in this study. 
In conclusion, this study reveals relations between genetic variation at the 5HTTLPR 
locus, including rs25531, and increased severity of tics and comorbid ADHD, OCD, and 
ASD symptoms. Presence of a MAOA uVNTR high-activity allele was associated with 
decreased severity of comorbid ASD features, which points to a possible protective 
influence of MAOA regarding ASD symptoms in patients with a tic disorder. Moreover, 
delivery complications were associated with comorbid ADHD symptoms, and prenatal 
exposure to smoking with symptoms of ADHD and ASD. An interesting finding is that 
the relation between delivery complications and tic severity may be more pronounced 
in the absence of a MAOA uVNTR high-activity allele. Future research directed at 
replication of our findings and investigation of the underlying pathophysiological 
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In the current study we investigated the role of the dopamine receptor (DR) D4 48 
base pairs (bp) variable number of tandem repeats (VNTR) and perinatal adversities 
regarding severity of tics and comorbid symptoms in children with tic disorders. We 
genotyped 110 children with tics with regard to the 48-bp VNTR and assessed 
presence of prenatal smoking exposure, and pregnancy and delivery complications 
by parent questionnaires. We examined associations between 2, 3, 4, and 7 repeat 
(R) alleles and severity of tics and comorbid obsessive-compulsive, depressive, 
anxious, and autistic symptoms. Through linear regressions, we investigated 
whether perinatal adversities and the 2R, 3R, 4R, and 7R alleles would interact with 
severity ratings of tics or comorbid symptoms as outcome. Presence of a 2R allele 
was related to more severe obsessive-compulsive symptoms, and presence of a 3R 
allele to increased severity of autistic features. Pregnancy complications were 
associated with decreased obsessive-compulsive symptom severity, and prenatal 
smoking exposure to more severe depressive and autistic symptoms. In children 
without a 3R allele delivery complications were associated with more severe tics, 
but in children with a 3R variant an inverse relation between delivery complications 
and tic severity was found. Moreover, the relation between delivery complications 
and internalizing symptom severity appeared to be most pronounced in children 
with a 2R allele. In conclusion, this study provides evidence for a role of the 48-bp 
VNTR in the etiology of tic and associated disorders, and for interactions with 





Tic disorders are often accompanied by a variety of psychiatric disorders and 
symptoms, such as attention deficit/hyperactivity disorder (ADHD), obsessive-
compulsive disorder (OCD), major depressive disorder (MDD), anxiety disorders, and 
autism spectrum disorder (ASD).
1
 Whereas ADHD, OCD, and ASD may share an 
underlying genetic vulnerability with tic disorders
2,3
, internalizing disorders in patients 
with tics may have an independent etiology.
4
 However, different comorbidities may as 
well represent distinctive phenotypic subgroups. The search for genes could therefore 
be facilitated by subdividing patients with tics according to comorbid symptoms.
5
 
Dopaminergic genes are suitable candidates for the study of tic disorders given that 
dopaminergic neurotransmission contributes to the etiology of tics.
6
 A gene of 
particular interest is the dopamine receptor (DR) D4 gene which inhibits cyclic 
adenosine monophosphate (cAMP), and also influences arachidonic acid release and 
ion channels. A variable number of tandem repeats (VNTR), characterized by a 
sequence of 48 base pairs (bp) with two to eleven repeats (R), is located on the third 
exon. The functional significance of the DRD4 exon III 48-bp VNTR is still under 
debate
7




Studies regarding the 48-bp VNTR in tic and associated disorders have shown 
inconsistent results. A higher frequency of the 7R variant in patients with Tourette’s 
disorder (TD) has been reported
9
, but could not be confirmed in a later study.
10
 Two 
family-based studies have found biased transmission in favor of the 7R allele, but two 
other studies found balanced transmission in probands with a chronic tic disorder.
10-13
 
In patients with OCD, lower frequencies of the 4R allele but no transmission 
disequilibrium
14
, lower frequencies and absent transmission of the 2R variant
15
 as well 
as reduced transmission of the 4R allele and slightly increased transmission of the 2R 
and 7R alleles
16
 have been found. Associations of the 2R allele with (symptoms of) 
MDD and anxiety have also been reported.
17-19
 However, in panic disorder and social 
phobia, balanced transmission of the 48-bp VNTR has been found.
20,21
 Regarding ASD, 




Notwithstanding the unequivocal role of genetic factors, perinatal adversities may 
also contribute to, or interact with genes to modulate the severity of tic and co-
occurring disorders.
23-25
 Our group has provided indirect, preliminary evidence of the 
involvement of an interaction between smoking exposure in utero and the presence of 
a positive family history of mental disorders in symptom severity of ADHD in children 
with a tic disorder.
26
 
In the current study, we examined relations of the DRD4 48-bp VNTR and perinatal 
adversities with severity of tics and comorbid OCD, MDD, anxiety, and ASD symptoms 








The study involved 110 patients with a tic disorder between 6 and 18 years (mean age 
12.3 years [SD 3.0]; 81.8% male) of which 75 patients had previously participated in a 
study on perinatal adversities.
26
 Most of the patients (n = 86) had been referred to our 
outpatient child and adolescent psychiatry clinic, the remaining (n = 24) were recruited 
through the Dutch TD Association. Patients fulfilled criteria of the Diagnostic and 
Statistical Manual of Mental Disorders fourth edition, text revised (DSM-IV-TR)
27
 for 
either TD (n = 96; 87.3%), chronic motor tic disorder (n = 12; 10.9%), or chronic vocal 
tic disorder (n = 2; 1.8%). At the time of investigation, parents indicated their child’s 
use of psychotropic medication. Psychotropic medication was used by 54.5% of 
patients (n = 60), either an antipsychotic agent (n = 21), clonidine (n = 7), 
methylphenidate (n = 8), atomoxetine (n = 4), a selective serotonin reuptake inhibitor 
(n = 2), or a combination of two or more agents (n = 18). 
Informed consent from parents and children of 12 years or older, and assent from 
children between 6 and 12 years was obtained. The study had been approved by our 
Institutional Review Board. 
 
Clinical measures 
Parents were interviewed regarding their child’s worst ever tic severity by using the 
Yale Global Tic Severity Scale (YGTSS).
28
 However, assessment of worst ever tic severity 
had not yet been introduced at the first stage of the study and is therefore not 
available in a subgroup of patients (n = 39); here, we used current tic severity ratings. 
The YGTSS records the number, frequency, intensity, complexity, and interference of 
motor and vocal tics separately on a five-point scale. The sum of both scores is used as 
a measure of total tic severity, with maximum motor and vocal scores of 25, and total 
score of 50. Mean total, motor, and vocal YGTSS ratings were 23.0 (SD 9.5, range 4 - 
47), 14.4 (SD 5.5, range 0 - 25), and 8.7 (SD 6.6, range 0 - 23), respectively. 
The Children's Yale-Brown Obsessive-Compulsive Scale (CYBOCS) was used to 
interview parents regarding their child’s obsessive-compulsive symptom severity 
(available from 107 patients).
29
 Mean total, obsessive, and compulsive CYBOCS ratings 
were 5.0 (SD 7.3, range 0 - 28), 1.8 (SD 3.9, range 0 - 16), and 3.1 (SD 4.6, range 0 - 16), 
respectively. 
The parent version of the Children’s Social Behavior Questionnaire (CSBQ) was 
administered to investigate severity of ASD features (available from 104 patients).
30
 
The CSBQ contains 49 items to be scored on a three-point scale (0 = the behavior does 
not apply to the child, 1 = sometimes or somewhat applies, 2 = clearly or often applies) 
which refer to six empirically derived subscales: not tuned (i.e., not optimally tuned to 
4 
51 
 the social situation; mean 9.0 [SD 6.1, range 0 - 29]), reduced social interest (mean 4.5 
[SD 4.6, range 0 - 17]), orientation problems (i.e., orientation problems in time, place, 
or activity; mean 5.4 [SD 4.7, range 0 - 23]), not understanding (i.e., difficulties in 
understanding of social information; mean 4.5 [SD 3.8, range 0 - 14]), resistance to 
changes (mean 2.3 [SD 4.5, range 0 - 27]), and stereotyped behavior (mean 3.6 [SD 3.3, 
range 0 - 13]). The sum of the subscales can be used as a measure of total ASD 
symptom severity (mean 29.4 [SD 19.0, range 1 - 88]). 
To assess the severity of anxiety and depressive symptoms, we used the Revised 
Child Anxiety and Depression Scale (RCADS), a questionnaire with 47 items 
corresponding to DSM-IV MDD and anxiety disorders (i.e., separation anxiety disorder, 
social phobia, generalized anxiety disorder, OCD, and panic disorder) and scored on a 
three-point scale (0 = never, 1 = sometimes, 2 = often, 3 = always).
31
 As we added the 
RCADS to our clinical measures after the start of the study, only the parents of 63 
patients filled out the questionnaire. We used the MDD subscale and the sum of the 
five anxiety subscales as severity measures of depressive and anxiety symptoms, 
respectively. Respective mean total, total anxiety, and MDD ratings were 27.1 (SD 19.0, 
range 2 - 82), 20.8 (SD 15.7, range 1 - 68), and 6.4 (SD 4.1, range 0 - 17). 
Parents also completed questionnaires with regard to pregnancy and delivery 
complications, and maternal prenatal smoking (available from 87 patients). Long-term 
maternal recall has been demonstrated to be accurate for many perinatal adversities.
32
 
Pregnancy complications could include hypertension, infections, (pre)ecclampsia, 
psychosocial stress, or diabetes mellitus, and were present in 39 patients (44.8%). 
Presence of meconium-stained amniotic fluid, premature rupture of the membranes, 
nuchal cord, fetal bradycardia, placenta praevia, or artificial delivery was classified as a 
delivery complication, present in 33 patients (37.9%). Smoking during pregnancy was 
reported by 14 mothers (16.1%). 
 
Genotyping 
DNA was extracted from blood samples 
or buccal swabs (Cytobrush
®
) using a 
previously described manual salting out 
procedure.
33
 The DRD4 exon III 48-bp 
VNTR was genotyped in a quality-
certified laboratory at the Department 
of Human Genetics of the Radboud 
University Medical Center, Nijmegen, 
the Netherlands. Genotyping was 
performed after amplification from 10 
ng genomic DNA in a 10 μl volume with 
0.5 μM fluorescently labelled forward 
(Vic-5’-GCGACTACGTGGTCTACTCG-3’) 
and reverse primer (5’-
AGGACCCTCATGGCCTTG-3’), 0.4 mM 
Table 1 
Allele frequencies of the dopamine receptor 
D4 48 base pairs variable number of tandem 
repeats in our sample comprising children 
with a tic disorder. 
Alleles n % 
2R 18 8.2 
3R 14 6.4 
4R 141 64.1 
5R 1 0.5 
6R 1 0.5 
7R 43 19.5 
8R 2 0.9 





deoxyribonucleotide triphosphates, and 0.5 U La Taq (Takara, Lonza Verviers Sprl, 
Verviers, Belgium), in GC I buffer (Takara) with 1 M betaine. The cycling conditions 
were 1 minute at 94°C, 35 cycles of 30 seconds at 94°C, 30 seconds at 58°C, 1 minute 
at 72°C, and an extra 5 minutes at 72°C. Three percent blanks as well as duplicates 
between plates were taken along as quality controls during genotyping. Subsequent 
determination of the length of the alleles was performed by direct analysis on an 
automated capillary sequencer (ABI3730, Applied Biosystems, Nieuwerkerk a/d IJssel, 




We made between-group comparisons between those individual 48-bp VNTR alleles 
with an allele frequency higher than 2%: 2R, 3R, 4R, and 7R. We tested between-group 
differences by using one-way independent analysis of variance (ANOVA) regarding the 
tic and comorbid symptom severity ratings. If a tic or comorbid symptom severity 
measure yielded a statistically significant difference between the individual alleles, 
Hochberg’s GT2 Post hoc analyses were performed because of different sample sizes. 
Pregnancy and delivery complications, and prenatal smoking exposure were 
dichotomized into presence and absence of pregnancy complications, presence and 
absence of delivery complications, and presence and absence of prenatal smoking 
exposure. We made between-group comparisons by using Student’s t test, regarding 
the tic and comorbid symptom severity measures. 
Furthermore, those perinatal adversities, that appeared to yield between-group 
differences meeting a significance level of at least p < .20 with regard to a tic or 
comorbid symptom severity measure, were used in linear regression as independent 
variable together with interaction terms of the perinatal adversity with the presence of 
the 2R, 3R, 4R, or 7R allele and the tic or comorbid symptom severity measure as 
outcome. Those regression analyses demonstrating a statistically significant interaction 
term in association with a tic or comorbid symptom severity measure were 
subsequently adjusted for gender and age. 
In all statistical analyses p ≤ .05 was considered as significant and tests were two-
sided. 
Results 
DRD4 48-bp VNTR 
Table 2 shows comparisons between patients with a 2R, 3R, 4R, and 7R allele, revealing 
statistically significant between-group differences regarding obsessive and total 
CYBOCS, and CSBQ subscale not understanding ratings. Post hoc analyses showed that 
the 2R allele was significantly associated with higher obsessive CYBOCS ratings 




 Table 2 
Comparisons between 2R, 3R, 4R, and 7R alleles of the dopamine receptor D4 48 base 
pairs variable number of tandem repeats regarding severity of tics and comorbid 
symptoms in children with a tic disorder. 
  2R 3R 4R 7R  
  n mean SD n mean SD n mean SD n mean SD df F p 
YGTSS  14   6   92   27   3, 135   
motor  17.6 4.5  17.8 1.2  16.2 4.3  15.3 6.1  0.99 .40 
vocal  11.7 7.4  8.2 9.0  8.8 6.7  10.4 6.6  1.06 .37 
total  29.4 9.8  26.0 8.8  25.0 8.1  25.7 8.6  1.10 .35 
                 
CYBOCS 18   13   138   42   3, 208   
obsessive  4.8 5.4  2.9 5.6  1.8 3.7  0.4 1.2  6.41 .0003¹ 
compulsive  4.3 4.9  5.1 5.9  3.1 4.5  2.3 4.1  1.69 .17 
total  9.1 8.5  8.0 10.6  4.9 7.2  2.7 4.9  4.23 .006² 
                 
CSBQ 18   13   132   41   3, 200   
not tuned  7.4 6.2  10.6 5.8  9.3 6.0  8.6 6.1  0.90 .44 
reduced social 
interest 
 5.6 6.1  4.8 5.0  4.5 4.5  3.8 3.9  0.68 .57 
orientation 
problems 
 4.3 3.0  7.3 4.1  5.5 4.9  5.4 5.0  1.01 .39 
not 
understanding 
 4.4 4.2  7.5 4.0  4.5 3.7  3.8 3.2  3.29 .02³ 
resistance to 
changes  
 1.4 1.5  1.8 1.4  2.5 4.6  2.6 5.8  0.36 .78 
stereotyped 
behavior 
 3.3 3.6  4.8 4.4  3.7 3.3  3.3 2.9  0.72 .54 
total  26.6 18.1  36.8 19.9  29.9 18.7  27.5 19.0  0.98 .40 
                 
RCADS 13   4   84   22   3, 119   
MDD  5.6 4.2  4.3 4.0  7.0 4.3  5.3 3.4  1.57 .20 
total anxiety  19.8 19.6  7.3 6.8  22.4 15.5  18.8 14.4  1.44 .24 
total  25.5 23.1  11.5 10.7  29.4 18.9  24.1 16.9  1.53 .21 
R, repeats; YGTSS, Yale Global Tic Severity Scale; CYBOCS, Children's Yale-Brown Obsessive-Compulsive Scale; 
CSBQ, Children’s Social Behavior Questionnaire; RCADS, Revised Child Anxiety and Depression Scale; MDD, 
major depressive disorder. Between-group differences were tested by using one-way independent analysis 
of variance. Between-group differences meeting the significance level (p ≤ .05) are bold marked. ¹Hochberg's 
GT2 Post Hoc tests: mean obsessive CYBOCS difference between 2R and 4R: 3.0 (SE 0.9), p = .008; and 
between 2R and 7R: 4.4 (SE 1.0), p = .0002. ²Mean total CYBOCS difference between 2R and 7R: 6.4 (SE 2.0), 
p = .01. ³Mean not understanding CSBQ difference between 3R and 4R: 3.0 (SE 1.1), p = .04; and between 3R 




the 7R allele (figure). CSBQ subscale not understanding ratings were higher in the 
presence of a 3R allele compared to the 4R and 7R alleles. 
 
Perinatal adversities 
Patients with pregnancy complications had lower mean compulsive CYBOCS ratings 
(2.0 [SD 3.7] versus 3.9 [SD 4.9], t = 2.02, p = .05). Patients who had been exposed to 
smoking in utero had higher mean MDD RCADS (9.1 [SD 4.1] versus 6.1 [SD 4.1], t = -
2.05, p = .05) and CSBQ subscale orientation ratings (6.6 [SD 3.8] versus 4.4 [SD 3.7], t = 
-1.98, p = .05). No other statistically significant associations between a perinatal 
adversity and any symptom severity measure were present. 
 
Gene-environment interactions 
The interaction term of delivery complications and the 3R allele was significantly 
related to mean total YGTSS ratings (b = -15.87, SE 6.3, β = -.34, p = .01), also after 
adjusting for age and gender (b = -14.79, SE 6.3, β = -.32, p = .02). In the presence of a 
3R allele, delivery complications were statistically significantly associated with lower 
mean total YGTSS ratings (25.6 [SD 10.8] versus 38.3 [SD 4.6], t = 2.63, p = .03), while in 
the absence of a 3R allele, delivery complications were associated with higher mean 
total YGTSS ratings (26.3 [SD 10.4] versus 23.2 [SD 8.0], t = -1.97, p = .05). 
The interaction term of delivery complications and the 2R allele was statistically 
significantly associated with total anxiety (b = 28.41, SE 10.3, β = .33, p = .007) and 














2R 3R 4R 7R
Figure. Associations between presence of 2R, 3R, 4R, and 7R alleles of the dopamine 
receptor D4 48 base pairs variable number of tandem repeats and severity of 
obsessive-compulsive symptoms in children with a tic disorder.
mean obsessive CYBOCS ratings













CYBOCS, Children's Yale-Brown Obsessive-Compulsive Scale; R, repeats.
 and gender (b = 30.02, SE 10.2, β = .35, p = .004, and b = 35.06, SE 12.4, β = .33, p = 
.006, respectively). In the presence of a 2R allele, delivery complications were 
statistically significantly associated with higher mean total anxiety (44.8 [SD 16.4] 
versus 10.7 [SD 5.0], t = -4.90, p = .001), and total RCADS ratings (55.0 [SD 18.6] versus 
14.3 [SD 6.8], t = -5.01, p = .001). In the absence of a 2R allele, delivery complications 
were not associated with mean total anxiety (25.6 [SD 19.8] versus 19.9 [SD 13.5], t = -
1.40, p = .17), and total RCADS ratings (33.3 [SD 23.5] versus 26.0 [SD 16.6], t = -1.51, p 
= .14). 
No other statistically significant interaction terms of perinatal adversities with 
DRD4 48-bp VNTR alleles in association with a tic or comorbid symptom severity 
measure were present. 
Discussion 
The present study demonstrates a contribution of the DRD4 48-bp VNTR to severity of 
tics and comorbid symptoms in children with a tic disorder. Presence of a 2R allele was 
related to more severe OCD symptoms, and presence of a 3R allele to increased 
severity of ASD symptoms. These findings support the involvement of dopaminergic 
neurotransmission in the etiology of comorbid OCD and ASD, as is also suggested by 
findings from pharmacological and neuroimaging studies
14,34,35
: effectiveness of 
antipsychotic medication (in combination with selective serotonin reuptake inhibitors) 
in patients with OCD and for aggression, irritability, and self-injurious behavior in 
patients with ASD
14,34,35
, and higher dopamine transporter densities and down-
regulation of D2 receptors in patients with OCD as demonstrated by positron emission 





 have also investigated tic severity in relation to the 48-bp VNTR in 
103 children with TD (mean age 13 ± 4.5 years), and found, in line with our study 
results, no relation between the 7R allele and tic severity. However, that study had not 
considered variants other than the 7R variant. Regarding comorbid OCD and ASD 
symptoms in patients with tic disorders, no studies had investigated possible relations 
with the 48-bp VNTR so far. All studies addressing OCD and ASD as such, have focussed 
on diagnostic entities, rather than severity of symptoms. Only one study has 
investigated possible relationships of the 48-bp VNTR with presence of autism (in 68 
children compared to 826 healthy controls), but no association could be revealed.
22
 
Regarding OCD, slightly increased transmission of the 2R allele, and also of the 7R 
allele as well as reduced transmission of the 4R allele has been identified in 69 trios 
comprising Caucasian probands (mean age 13.2 ± 2.7 years) and their parents.
16
 On the 
contrary, absent transmission of the 2R allele in 55 French probands with OCD (mean 
age 23.5 ± 10.3 years), and lower frequencies of the 2R allele and 2R-containing 
genotypes in the patients compared to 63 healthy controls have been found.
15
 
Mexican patients with OCD (N = 210; mean age 25.9 ± 10.4 years) had a lower 






 These inconsistencies may at least partly be due to the 
inclusion of adults in the latter two studies. Moreover, the different allele frequencies 
in the samples complicate the comparison of the studies. 
Our findings of smoking exposure in utero to be related to more severe depressive 
and autistic symptoms are in line with an expanding amount of studies suggesting that 
prenatal smoking exposure leads to vulnerability for these symptoms.
36-38
 We also 
found, however, an inverse relation between pregnancy complications and OCD 
symptom severity. Two previous studies had indicated delivery complications and 




We also found evidence of gene-environment interactions in tic disorders: in the 
presence of delivery complications children without a 3R allele had more severe tics, 
whereas children with a 3R variant had decreased tic severity. Moreover, the relation 
between delivery complications and severity of internalizing symptoms appeared to be 
most pronounced in children with a 2R allele. No other studies have investigated 
interactions between the 48-bp VNTR and perinatal adversities in children with tic 
disorders. However, the presence of an interaction between prenatal exposure to 
smoking and the 7R allele has been suggested in children with ADHD, although studies 
have shown inconclusive results.
40,41
 
A number of limitations need to be acknowledged. First, the sample size of our 
study group has been relatively small. Thereby, severity of internalizing features was 
only assessed in a subgroup of patients. Another disadvantage of our study has been 
the retrospective collection of worst ever tic severity. Finally, the use of psychotropic 
medication in 55% of the patients may have affected symptom severity. 
In conclusion, the present study provides evidence for the 2R allele of the DRD4 48-
bp VNTR as a genetic risk factor for OCD symptom severity, and the 3R allele for ASD 
symptom severity in children and adolescents with a tic disorder. The findings of 
interactions between delivery complications and the 3R allele regarding tic severity, 
and the 2R allele regarding depressive and anxious symptoms, would be strengthened 
by independent replication. Future studies should address further DRD4 
polymorphisms and the pathophysiological mechanisms underlying the involvement of 
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Objective To investigate the role of single nucleotide polymorphisms (SNPs) of the 
solute carrier family 6, member 3, gene (SLC6A3) regarding severity of tics and 
comorbid symptoms in patients with a tic disorder. 
Methods We genotyped 132 patients with tics with regard to three SNPs located at the 
3’ and 5’ ends of SLC6A3 (rs40184, rs11564750, and rs2550946) and assessed 
severity of tics and symptoms of comorbid obsessive-compulsive disorder and 
attention deficit/hyperactivity disorder as well as presence of prenatal smoking 
exposure and pregnancy and delivery complications. Possible associations between 
SNP alleles and severity of tics and comorbid symptoms were addressed. Also, 
through linear regressions, we investigated whether SNP alleles would interact with 
perinatal adversities regarding tic and comorbid symptom severity. 
Results Presence of an rs40184 G allele was associated with increased severity of 
inattentive symptoms. Thereby, pregnancy complications appeared to interact with 
rs11564750 and rs2550946 to decrease severity of comorbid obsessions and 
compulsions. 
Conclusion This study provides preliminary evidence for a role of SLC6A3 in the 
expression of comorbid inattentive symptoms in patients with a tic disorder. 
Interactions between SLC6A3 and pregnancy complications may modulate severity 




Tic disorders are neuropsychiatric conditions characterized by the presence of sudden, 
rapid, recurrent, and nonrhythmic movements, and/or utterances. Many patients with 
tics are affected by a variety of comorbid psychiatric conditions and symptoms 
including obsessive-compulsive disorder (OCD) and attention deficit/hyperactivity 
disorder (ADHD).
1
 Underlying etiological mechanisms are still under debate. Although 
genes indisputably contribute to the pathogenesis of tics, no genetic susceptibility 
regions have conclusively been identified.
2
 Findings of family studies have suggested 
that tic disorders and at least some forms of OCD and ADHD may be different 
expressions of a shared genetic vulnerability
3-5
, whereas other studies have indicated 
that tics and ADHD may have independent etiologies, and that patients with tics as 
well as ADHD and OCD may represent a separate nosological entity.
6
 However, most 
studies have searched for genetic variants involved in tic disorders without taking 
comorbidities into account. 
Postmortem and single photon emission computer tomography (SPECT) studies 
have indicated that the dopamine transporter may be involved in Tourette´s disorder.
7-
9
 Moreover, dopamine blocking agents are well established treatments for tic 
disorders. This has made the dopamine active transporter-1 gene (DAT1, alias solute 
carrier family 6, member 3 gene [SLC6A3]) that regulates synaptic concentrations of 
dopamine by reuptake into presynaptic ends an obvious candidate gene for tic 
disorders.
2
 The majority of studies has confirmed a role of SLC6A3 in tic and co-
occurring disorders, although results have been elusive.
10-24
 Most work has addressed 
an SLC6A3 40 base pairs (bp) variable number of tandem repeats (VNTR) with 3 till 13 
repeats (R) located at the 3' untranslated region. Associations between the 9R allele 
and increased tic severity in children with Tourette's disorder
10
, and between the 10R 
allele and 10R/10R genotype and presence of a tic disorder have been demonstrated in 
both family-based and case-control studies
11,12
, but could not be replicated in two 
other studies.
13,14
 Heterozygosity for alleles of another SLC6A3 polymorphism, named 
DAT1 DdeI, has also been related to presence of Tourette's disorder.
13
 Evidence for a 
role of SLC6A3 in OCD is much weaker. Here, two studies have found trends toward 
increased frequencies of the 9R allele of the 3’ VNTR in patients with OCD compared to 
healthy controls
15,16
, while two other investigations found no differences.
17,18
 Also in 69 
trios comprising probands with early onset OCD and their parents no evidence of 
transmission disequilibrium has been detected for alleles of the 3’ VNTR.
19
 
Several studies have also indicated a role for SLC6A3 polymorphisms in ADHD. The 
large scale international multi-site ADHD genetics study
20
 investigated 32 single 
nucleotide polymorphisms (SNP) and four VNTR markers spanning SLC6A3 in 776 trios 
of patients with combined type ADHD and their parents and found nominal evidence 
of associations with six SNP markers and three VNTR markers. Two groups of markers 




within in each region, but not between the two regions, exhibited high linkage 
disequilibrium. In a subsequent investigation of the same research group
21
, four SNP 
markers were addressed: two located at the 5' end (rs2550946 and rs11564750), one 
in intron 10 (rs3776153), and one at the 3' end of intron 14 (rs40184). ADHD appeared 
to be related to rs11564750 and rs3776153. Recently, an independent group has 
replicated the association between rs11564750 and ADHD in 450 trios comprising 
probands with ADHD and their parents.
22
 
The main aim of the current study was to investigate possible associations between 
three SLC6A3 SNP markers (rs40184, rs11564750, and rs2550946) and severity of tics 
and comorbid OCD and ADHD symptoms in patients with a tic disorder. Genetic 
research in tic disorders may be complicated by substantial environmental influences 
that modulate or interact with gene effects. In a previous study, we have 
demonstrated that gene-environment interactions between the dopamine receptor D4 
gene and delivery complications may be associated with tic and internalizing symptom 
severity in children with tic disorders.
25
 Evidence pointing to a role of interactions 
between SLC6A3 and prenatal adversities in ADHD has been provided.
26-28
 Therefore, 
we also explored possible interactions between the SLC6A3 SNP markers and perinatal 
adversities in patients with tics and comorbid symptoms. 
Methods 
Study sample 
The study involved 132 patients with a tic disorder between 6 and 60 years (mean age 
15.6 years [SD 10.2]; 14% of 18 years or older; 79.5% male), of which 65 patients had 
previously participated in a study investigating perinatal adversities.
29
 Most of the 
patients (n = 96) had been referred to our outpatient child and adolescent psychiatry 
clinic, the remaining (n = 36) were recruited through the Dutch Tourette's disorder 
Association. Patients fulfilled criteria of the Diagnostic and Statistical Manual of Mental 
Disorders fourth edition, text revised (DSM-IV-TR)
30
 for either Tourette's disorder (n = 
116), chronic motor tic disorder (n = 15), or chronic vocal tic disorder (n = 1). At the 
time of investigation, the use of psychotropic medication was recorded (available from 
125 patients). This was used by 64 patients, either an antipsychotic agent (n = 22), 
clonidine (n = 7), methylphenidate (n = 8), atomoxetine (n = 4), a selective serotonin 
reuptake inhibitor (SSRI; n = 3), or a combination of two or more agents (n = 20). 
Informed consent from patients of 18 years or older, from parents and children of 
12 years or older, and assent from children between 6 and 12 years was obtained. The 
study had been approved by our Institutional Review Board. 
 
Clinical measures 
Patients were interviewed regarding their tic severity, with regard to the week in 
which tics were worst ever, by using the Yale Global Tic Severity Scale (YGTSS), a semi-
structured interview which records the number, frequency, intensity, complexity, and 
5 
65 
 interference of motor and vocal tics separately.
31
 In a subgroup of patients (n = 57), 
worst ever tic severity had not been assessed; here, we used current tic severity 
ratings. Mean total, motor, and vocal YGTSS ratings were 22.6 (SD 9.6, range 4 - 50), 
13.9 (SD 5.4, range 0 - 25), and 8.7 (SD 6.5, range 0 - 25), respectively. 
Pediatric or adult versions of the Yale-Brown Obsessive-Compulsive Scale (YBOCS) 
as appropriate were used to interview patients regarding their current obsessive-
compulsive symptom severity (available from 121 patients).
32
 Mean total, obsessive, 
and compulsive YBOCS ratings were 5.0 (SD 7.5, range 0 - 28), 1.9 (SD 3.9, range 0 - 
16), and 3.1 (SD 4.6, range 0 - 16), respectively. 
ADHD symptom severity was measured by using the parent version of the ADHD 
rating scale (available from 65 children), a DSM-IV based questionnaire containing 18 
items on inattentive and hyperactive-impulsive symptoms to be scored on a four-point 
scale.
33
 Respective mean total, hyperactive-impulsive, and inattentive scores were 19.9 
(SD 11.1, range 1 - 43), 8.7 (SD 6.6, range 0 - 23), and 11.0 (SD 5.9, range 0 - 22). ADHD 
symptom ratings were not available for the adult patients. 
Patients also completed questionnaires with regard to pregnancy and delivery 
complications, and maternal prenatal smoking (available from 90 patients), as has 
been described before.
29
 Pregnancy complications were present in 40 patients, 




DNA was extracted from blood samples or buccal swabs (Cytobrush
®
) using a manual 
salting out procedure.
34
 We genotyped one SNP from the 3’ end (rs40184) and two 
SNPs markers located at the 5’ end (rs11564750 and rs2550946) of the SLC6A3 gene by 
using the Illumina BeadStation 500 platform (Illumina Inc., San Diego, CA, USA). Scan 
data were analyzed and genotyped in BeadStudio 3.0 (Illumina Inc., San Diego, CA, 
USA). Call rates were 98% for rs40184, 100% for rs11564750, and 99% for rs2550946. 
Genotyping accuracy was 100% as determined by concordance between DNA 
replicates. Minor allele frequencies and positions in the SLC6A3 gene are represented 
in table 1. 
 
Table 1  
Position in the solute carrier family 6, member 3, gene, alleles, and minor allele 
frequency of the investigated SNP markers. 
SNP marker  Position in gene (bp) Location Alleles MAF 
rs40184 1,448,077 3´ flanking of intron 14 A/G 0.43 
rs11564750 1,500,762 5´ flanking C/G 0.11 
rs2550946 1,503,513 5´ flanking A/G 0.39 








  A G   
  n mean ± SD n mean ± SD t p 
YGTSS  102  158    
motor  14.0 ± 5.4  13.8 ± 5.4 0.31 .76 
vocal  8.7 ± 6.3  8.4 ± 6.5 0.34 .74 
total  22.7 ± 9.3  22.2 ± 9.7 0.41 .69 
YBOCS 90  148    
obsessive  2.1 ± 3.9  1.6 ± 3.8 1.01 .31 
compulsive  3.6 ± 4.6  2.7 ± 4.5 1.44 .15 
total  5.7 ± 7.4  4.3 ± 7.3 1.46 .15 
ADHD  
rating scale  
48  78    
inattentive  9.7 ± 6.4  11.6 ± 5.5 -1.79 .08 
hyperactive-
impulsive 
 8.0 ± 6.8  9.1 ± 6.6 -0.96 .34 
total  18.1 ± 11.8  20.8 ± 10.7 -1.36 .18 
SNP, single nucleotide polymorphism; OCD, obsessive-compulsive 
disorder; ADHD, attention deficit/hyperactivity disorder; YGTSS, Yale 




Comparisons between alleles of SNP markers of the solute carrier family 6, member 3, 
gene regarding severity of tics and comorbid OCD and ADHD symptoms in patients 
with a tic disorder. 
 rs40184 rs11564750 
  A G   C G   
  n mean ± SD n mean ± SD t p n mean ± SD n mean ± SD t p 
YGTSS  117  145    31  233    
motor  13.7 ± 5.2  14.0 ± 5.6 -0.43 .67  13.7 ± 5.4  14.0 ± 5.5 -0.27 .79 
vocal  8.1 ± 6.4  9.0 ± 6.5 -1.11 .27  8.1 ± 6.5  8.8 ± 6.5 -0.52 .61 
total  21.8 ± 9.2  23.0 ± 9.8 -0.99 .32  21.8 ± 9.0  22.7 ± 9.7 -0.50 .62 
YBOCS 102  138    27  215    
obsessive  1.9 ± 3.9  1.7 ± 3.7 0.52 .61  2.0 ± 4.2  1.8 ± 3.9 0.16 .88 
compulsive  3.3 ± 4.8  2.8 ± 4.3 0.88 .38  4.3 ± 5.1  2.9 ± 4.5 1.51 .13 
total  5.3 ± 7.6  4.4 ± 7.1 0.86 .39  6.3 ± 8.1  4.8 ± 7.4 0.99 .33 
ADHD  
rating scale  
54  74    15  115    
inattentive  9.5 ± 6.3  11.9 ± 5.5 -2.34 .02  11.1 ± 7.0  11.0 ± 5.8 0.10 .93 
hyperactive-
impulsive 
 8.1 ± 6.1  9.2 ± 7.0 -0.91 .37  10.0 ± 6.6  8.5 ± 6.6 0.82 .41 
total  18.0 ± 10.9  21.2 ± 11.1 -1.61 .11  21.1 ± 11.4  19.8 ± 11.0 0.45 .65 
5 
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 Statistical analyses 
We made comparisons between alleles of the three SNPs, and between patients with 
and without at least one pregnancy complication, with and without at least one 
delivery complication, and with and without prenatal smoking exposure by using  
Student’s t test regarding ratings of tic and comorbid OCD and ADHD symptom 
severity. 
A gene x environment interaction term was provided by the product of genetic and 
perinatal factors. Regarding rs40184 and rs2550946, presence of an A allele was given 
the value 0, and of a G allele the value 1; with regard to rs11564750, presence of a C 
allele was given the value 0, and of a G allele the value 1. Those perinatal adversities 
that appeared to yield between-group differences at a significance level of at least p ≤ 
.25 with regard to a symptom severity measure were used in linear regression as 
independent variable together with these interaction terms with the symptom severity 
measures as outcome. Those regression analyses demonstrating a statistically 
significant interaction term in association with a symptom severity measure were 
subsequently adjusted for gender and age. 
In all statistical analyses p ≤ .05 was considered as significant and tests were two-
sided. 
Results 
Main effects of SNP markers 
Table 2 shows comparisons between the alleles of SNP markers rs40184, rs11564750, 
and rs2550946 with regard to the symptom severity ratings. Of note, presence of a G 
allele of SNP marker rs40184 was related to significantly higher mean inattentive 
ADHD rating scale scores. We found no other statistically significant between-group 
comparisons regarding any symptom severity measure. 
 
Perinatal adversities 
Patients who had been exposed to smoking in utero had lower mean motor YGTSS 
ratings (12.8 [SD 4.3] versus 15.8 [SD 5.1], t = 2.22, p = .03). No other statistically 
significant between-group comparisons regarding any perinatal adversity and any 
symptom severity measure were present. 
 
Gene-environment interactions 
The interaction term of pregnancy complications and rs11564750 was significantly 
related to mean compulsive and total YBOCS ratings (b = 6.20, SE 2.5, β = .69, p = .01, 
and b = 9.61, SE 4.1, β = .64, p = .02, respectively), also after adjusting for age and 
gender (b = 6.19, SE 2.5, β = .69, p = .01, and b = 9.68, SE 4.2, β = .64, p = .02, 
respectively). Figure 1 shows the direction of effect: in the presence of a C allele, 
pregnancy complications were associated with lower mean compulsive and total 




versus 11.0 [SD 9.1], t = -3.67, p = .005); whereas in the presence of a G allele, 
pregnancy complications were not associated with compulsive and total YBOCS ratings 
(2.4 [SD 3.8] versus 3.3 [SD 4.6], t = 1.34, p = .18, and 4.3 [SD 6.5] versus 5.3 [SD 7.8], t  
0.86, p = .38). Moreover, the interaction term of pregnancy complications and 
rs2550946 was significantly associated with mean total YBOCS ratings (b = 5.68, SE 2.3, 
β = .37, p = .01; after adjustment for age and gender: b = 5.83, SE 2.3, β = .38, p = .01). 
The direction of effect is represented in figure 2: in the presence of an A allele, 
pregnancy complications were related to lower mean total YBOCS ratings (3.6 [SD 5.2] 
versus 8.5 [SD 8.7], t = 2.70, p = .009); in the presence of a G allele, pregnancy 
complications were not associated with mean total YBOCS ratings (4.4 [SD 7.0] versus 
3.5 [SD 6.2], t = -0.64, p = .52). 
Regarding ADHD symptom severity, we found a statistically significant association 
of the interaction term of delivery complications and rs11564750 with mean 
inattentive ADHD rating scale scores (b = -8.69, SE 3.5, β = -.66, p = .02), also after 
adjusting for age and gender (b = -8.93, SE 3.5, β = -.67, p = .01). In the presence of a C 
allele, delivery complications were associated with higher mean inattentive ADHD 
rating scale scores (16.4 [SD 5.3] versus 5.6 [SD 3.6], t = -4.26, p = .002). However, in 
the presence of a G allele, delivery complications were at trend-level significance also 
associated with higher mean inattentive ADHD rating scale scores (11.4 [SD 5.2] versus 










mean compulsive YBOCS ratings mean total YBOCS ratings
Figure 1. Associations between interaction terms of pregnancy complications and rs11564750 regarding 
comorbid OCD symptom severity in patients with a tic disorder.
C allele - pregnancy complications (n = 5)
C allele - no pregnancy complications (n = 10)
G allele - pregnancy complications (n = 71)
G allele- -no pregnancy complications (n = 88)





 No other statistically significant interaction terms of perinatal adversities with any 
SNP marker in association with any symptom severity measure were present. 
Discussion 
The current study suggests an association between the G allele of the SLC6A3 SNP 
rs40184 and increased severity of inattentive symptoms in patients with a tic disorder. 
No previous studies have addressed SLC6A3 SNP markers in patients with tics, but in a 
large cohort of children with combined type ADHD a relation between rs40184 and 
ADHD status had also been identified.
20
 At least three studies in ADHD cohorts, 
however, have also detected associations between ADHD and SLC6A3 5´ end SNP 
markers, in contrast to the present study.
20-22
 One explanation may be that our sample 
size has been too small to detect the previously reported associations. The presently 
found trend-significant association between rs2550946 and severity of inattentive 
symptoms (p = .08) supports this. 
We did not find evidence of interactions between SNP markers of SLC6A3 and 
smoking or alcohol exposure in utero, in contrast to previous studies in ADHD 
cohorts.
26-28
 However, we found preliminary evidence for a role of gene-environment 
interactions in that pregnancy complications appeared to interact with 5´ flanking SNP 
markers to decrease severity of obsessions and compulsions: in the presence of an 
rs11564750 C allele or rs2550946 A allele, patients with pregnancy complications 













Figure 2. Associations between interaction terms of pregnancy complications and rs2550946 regarding 
comorbid OCD symptom severity in patients with a tic disorder.
A allele - pregnancy complications (n = 22)
A allele - no pregnancy complications (n = 37)
G allele - pregnancy complications (n = 52)
G allele - no pregnancy complications (n = 59)



















these SNP markers, pregnancy complications did not influence OCD symptom severity. 
In a previous study we had already found an inverse relation between pregnancy 
complications and OCD symptom severity in children with tics.
25
 Also, a trend-level 
significant relation between the number of medications exposed to during pregnancy 
and decreased OCD symptoms had previously been reported in a large cohort of 
patients with Tourette’s disorder.
35
 These findings suggest that pregnancy 
complications in some cases may protect against expression of OCD symptoms in 
patients with tics. This may perhaps be understood in that (subclinical) obsessive-
compulsive symptoms in some cases may actually be regarded as a healthy 
phenomenon with clear functionality for the individual. 
The presently reported associations between SLC6A3 and co-occurring OCD and 
ADHD symptoms in patients with tics support the involvement of dopaminergic 
pathways, in line with findings from pharmacological and neuroimaging studies. In 
patients with OCD antipsychotic medication has shown to be efficacious in 
combination with SSRIs.
36
 The dopamine transporter is a key target of 
methylphenidate, drug of first choice in ADHD.
37
 Moreover, SPECT studies have 
demonstrated an increased dopamine transporter binding ratio in the basal ganglia in 
patients with OCD and ADHD.
36,38,39
 Whereas a direct dopaminergic contribution to the 
pathogenesis of ADHD is obvious, dopamine may influence the expression of OCD by 
its interactions with the serotonin system. 
A number of limitations need to be acknowledged. First, the sample size of our 
study group has been relatively small. Another disadvantage has been the 
retrospective collection of worst ever tic severity. In addition, the use of psychotropic 
medication in 51% of the patients may have affected comorbid symptom severity. 
Worst ever tic severity, however, was typically in a time when children did not use 
psychotropic medication. Thereby, severity of ADHD features was only assessed in a 
subgroup of patients. Finally, the investigated markers may not be risk variants, but 
may interact with other polymorphisms of SLC6A3. 
In conclusion, this study addressed the possible role of SNP markers located at the 
3’ and 5’ regions of SLC6A3, both separately as well in interaction with perinatal 
adversities, regarding severity of tics and co-occurring OCD and ADHD symptoms in 
patients with a tic disorder. The SLC6A3 polymorphism rs40184 appeared to be 
associated with increased severity of comorbid ADHD features. The findings of 
interactions between pregnancy complications and SNP markers located in the 5' 
region of SLC6A3 regarding severity of comorbid obsessions and compulsions would be 
strengthened by independent replication. To facilitate the search for genes future 
studies regarding complex disorders such as tic disorders should take the expression of 
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Aim Dysregulation of the immune system may play a role in tic disorders. We screened 
for immune disturbances by investigating serum levels of cytokines and soluble 
adhesion molecules in patients with a tic disorder. 
Methods Serum levels of interleukin (IL)-2, IL-4, IL-5, IL-10, IL-12, soluble IL-2 receptor 
(sIL2R), tumor necrosis factor (TNF)-α, interferon (IFN)-γ, soluble vascular cell 
adhesion molecule-1 (sVCAM-1), and intercellular adhesion molecule-1 (sICAM-1) 
of 66 children and adolescents with a tic disorder and 71 healthy volunteers were 
compared. We also addressed possible relations between concentrations of the 
immune markers and severity of tics and comorbid obsessive-compulsive 
symptoms. 
Results Median serum concentrations did not differ significantly between patients and 
healthy subjects. Serum IL-2 concentrations were positively associated with tic 
severity ratings; serum IL-12 concentrations negatively with severity ratings of 
obsessive-compulsive symptoms. 
Conclusions These preliminary findings do not reveal major immune activation in 





Tic disorders are characterized by the presence of motor and/or vocal tics. However, 
the majority of patients with a tic disorder also suffer from other psychiatric 
conditions, mainly obsessive-compulsive disorder (OCD) and attention 
deficit/hyperactivity disorder (ADHD).
1
 Notwithstanding the genetic background of tic 
disorders
2
, environmental factors also account for at least a subgroup of patients with 
tics. A wealth of studies has addressed a broad range of immune related parameters in 
patients with tic disorders, but findings have been inconclusive so far.
3
 
Most research has focussed on the hypothesis of autoimmune processes being 
involved in tic disorders, but at best provided indirect support for this by 
demonstrating antineuronal antibodies
4-6
, decreased numbers of regulatory T cells 
(Treg) that maintain tolerance to self antigens
7
, and increased single time point serum 
levels of antistreptococcal antibodies
5,8,9
, and by identifying candidate auto-antigens
10-
12




Other studies have addressed dysregulation of the immune system in patients with 
tic disorders, in particular altered cellular immunity. Studies using microarray gene 
expression profiling of peripheral blood cells have demonstrated associations of 
Tourette’s disorder (TD) and comorbid ADHD with overexpression of natural killer (NK) 
and cytotoxic T cell genes.
15,16
 Also, serum levels of the proinflammatory cytokines 
interleukin (IL)-12 and tumor necrosis factor (TNF)-α have been found to be higher in 
children with TD and/or OCD compared to age-matched control subjects.
17
 Moreover, 
IL-12 and TNF-α levels were further increased during symptom exacerbations.
17
 A 
recent study enrolled 32 children with TD, including 17 patients with comorbid OCD, 
and 16 healthy subjects.
18
 Only the patients with TD and comorbid OCD had 
significantly elevated plasma IL-12 levels compared to controls, whereas IL-2 was 
significantly higher in patients with TD and OCD compared to patients without OCD. 
However, in a small group of children with OCD and/or a tic disorder in whom the 
onset and/or exacerbation of symptoms was related to group A β-hemolytic 
streptococcal infections (designated as PANDAS, i.e., pediatric autoimmune 
neuropsychiatric disorders associated with streptococcal infections)
19
, no relation 
could be demonstrated between symptom exacerbations and cytokine levels.
13
 
Cellular adhesion molecules are expressed by peripheral blood mononuclear cells 
and endothelial cells. These glycoproteins interact with other cells and the 
extracellular matrix and facilitate endothelial adhesion of circulating leukocytes during 
inflammation. Higher levels of soluble adhesion molecules, such as soluble vascular cell 
adhesion molecule-1 (sVCAM-1) and intercellular adhesion molecule-1 (sICAM-1) may 
be due to an increased expression of cellular adhesion molecules, mediated by 
inflammatory cytokines, or due to endothelial damage.
20
 In a study that included 51 
adult patients with TD, 30 healthy adults, 33 children with TD, 19 children with post-
streptococcal neuropsychiatric disorders (PANDAS or Sydenham’s chorea), and 34 
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healthy children, serum levels of sVCAM-1 appeared to be increased in adults and 
children with TD compared to healthy controls, whereas children with post-
streptococcal neuropsychiatric disorders had increased serum levels of sICAM-1 
compared to healthy children.
21
 
In the present study, we compared serum levels of the T helper (Th) 1 cytokines IL-
2, IL-12, TNF-α, and interferon (IFN)-γ, and the soluble IL-2 receptor (sIL2R) as markers 
of cellular immunity, of the Th2 cytokines IL-4, IL-5, and IL-10 that are mainly involved 
in humoral immune responses, and of soluble adhesion molecules sVCAM-1 and 
sICAM-1 between children and adolescents with a tic disorder and healthy volunteers. 
We also investigated possible relationships between serum levels of these 
immunological markers and severity of tics and comorbid obsessive-compulsive 
symptoms. 
Methods 
Patient and control subject populations 
The study involved 66 patients with a tic disorder (mean age 12.3 years [SD 3.2], range 
6 - 18; 86.4% male) and 71 healthy volunteers (mean age 12.5 years [SD 2.7], range 6 - 
18; 31.0% male). Gender ratios differed significantly between patients and controls (χ
2 
= 43.0, df =1, p < 0.001). Patients fulfilled criteria of the Diagnostic and Statistical 
Manual of Mental Disorders fourth edition, text revised
22
 for either TD (n = 45; 68.2%), 
chronic motor tic disorder (n = 19; 28.8%), or chronic vocal tic disorder (n = 2; 3.0%). At 
the time of investigation parents indicated their child’s use of psychotropic 
medication. Psychotropic medication was used by 56% of patients (n = 37), either 
antipsychotic agents (n = 11), clonidine (n = 3), psychostimulants (n = 7), atomoxetine 
(n = 4), or a combination of two or more agents (n = 12). Most of the patients (n = 52) 
had been referred to our outpatient child and adolescent psychiatry clinic, the 
remaining (n = 14) were recruited through the Dutch TD Association. Healthy 
volunteers had been recruited through advertisements in local news papers. Exclusion 
criteria were presence of an active infection, inflammation, autoimmune disorder, or 
autism. Healthy children who had a first-degree family member with tics were 
excluded as well. 
Informed consent from parents and children of 12 years or older, or assent from 
children between 6 and 12 years was obtained. The study had been approved by our 





 Assessment instruments 
Parents of the patients were interviewed regarding their child’s tic severity by using 
the Yale Global Tic Severity Scale (YGTSS).
23
 Mean total, motor, and vocal YGTSS ratings 
were 19.3 (SD 8.9, range 0 - 39), 12.4 (SD 4.8, range 0 - 21), and 6.9 (SD 5.8, range 0 - 
19), respectively. The Children's Yale-Brown Obsessive-Compulsive Scale (CYBOCS) was 
used to interview parents regarding their child’s obsessive-compulsive symptom 
severity.
24
 Mean total, compulsive, and obsessive CYBOCS ratings were 5.1 (SD 6.8, 
range 0 - 28), 3.3 (SD 4.3, range 0 - 14), and 1.8 (SD 3.7, range 0 - 16), respectively. 
 
Laboratory analyses  
Serum samples were collected between April 2006 and October 2007, and stored at -
20ºC until analysis in January 2008. Serum concentrations of IL-2, IL-4, IL-5, IL-10, IL-12, 
sIL2R, TNF-α, and IFN-γ were measured by using a multiplex cytokine array according 
to the manufacturer’s protocol (Invitrogen corporation, Carlsbad, CA) and read on a 
Luminex100™ platform. Detection limits of the assay were: IL-2 0.5 pg/ml, IL-4 0.5 
pg/ml, IL-5 0.1 pg/ml, IL-10 0.1 pg/ml, IL-12 2 pg/ml, sIL2R 5 pg/ml, IFN-γ 0.3 pg/ml, 
and TNF-α 0.1 pg/ml. When cytokine levels were below the limits of detection, 
cytokines were given the lowest detectable value. Serum concentrations of sICAM-1 
and sVCAM-1 were measured using a quantitative enzyme-linked immunosorbent 
assay following the protocol of the manufacturer (R&D systems; 
http://www.rndsystems.com). 
 
Data analyses  
We made comparisons between patients and healthy subjects by using the Mann-
Whitney U test with regard to serum concentrations of measured cytokines and 
soluble adhesion molecules. When cytokines were not detectable for more than 20% 
of either patients or healthy subjects, we subsequently investigated relations regarding 
the frequency of subjects with detectable levels by using Pearson Chi-Square test. 
Because gender ratios differed between patients and healthy subjects, we also 
made comparisons between male and female healthy subjects. As psychotropic 
medication may have induced immune alterations, we also compared patients with 
and without psychotropic medication use. Here, we also used the Mann-Whitney U 
test. 
We investigated possible relations of serum concentrations of cytokines and 
soluble adhesion molecules with severity ratings of tics and obsessive-compulsive 
symptoms by using Spearman’s correlation coefficient.  
In all statistical analyses p ≤ .05 was considered as significant. Tests were two-
sided. Given that we planned a total number of 10 patient-control comparisons and 60 
correlations, the significance levels corrected for the number of analyses would be .05 
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Table 1 
Serum concentrations of cytokines and soluble adhesion molecules in children with a 
tic disorder and healthy subjects. 
  Patients 
n = 66 
Healthy subjects 
n = 71 
 
 Median Median U z p 
      
Soluble adhesion molecules
 a
      
sVCAM-1  429 449 2197 -0.63 .53 
sICAM-1  148 160 2251 -0.40 .69 
      
Cytokines
b
      
IL-2 0.50 0.50 2099 -1.44 .15 
IL-4 1.14 2.95 1926 -1.84 .07 
IL-5 0.10 0.10 2160 -0.91 .36 
IL-10 1.69 1.64 2291 -0.22 .82 
IL-12 159 163 2255 -0.38 .71 
sIL2R 203 219 2201 -0.61 .54 
TNF-α 0.43 0.46 1966 -1.63 .10 
IFN-γ 0.30 0.30 1957 -1.83 .07 
U, Mann Whitney U test statistic; z , z-score; p , p-value;
 
sVCAM, soluble vascular cell adhesion molecule; 
sICAM, soluble intercellular adhesion molecule; IL, interleukin; sIL2R, soluble IL-2 receptor; TNF, tumor 
necrosis factor; IFN, interferon. 
a
Measured in nanograms per milliliter. 
b
Measured in picograms per milliliter.
 
Results 
Table 1 shows comparisons regarding median serum concentrations of cytokines and 
soluble adhesion molecules between patients and healthy subjects. Median serum 
concentrations did not differ significantly between patients and healthy subjects. Since 
sizeable portions of patients and controls had undetectable levels of IL-2 (patients 
82%, controls 73%), IL-4 (patients 44%, controls 30%), IL-5 (patients 92%, controls 
82%), IFN-γ (patients 83%, controls 66%), and TNF-α (patients 21%, controls 14%), we 
subsequently tested possible relations of disease status with frequency of detectable 
levels. Patients had only a significantly lower frequency of detectable IFN-γ levels 
compared to controls (χ
2 
= 5.3, df =1, p = 0.02). 
No gender differences regarding median serum concentrations of cytokines and 
soluble adhesion molecules were present, with the exception of median serum sICAM-
1 concentrations that were significantly higher in male healthy children compared to 
females (184.5 ng/ml versus 158.0 ng/ml, U = 356, z = -2.27, p = .02). Cytokine and 
soluble adhesion molecule levels did not differ between patients with and without 
psychotropic medication use, except median serum sIL2R concentrations that were 
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 significantly higher in patients who used psychotropic medication (253.4 pg/ml versus 
186.3 pg/ml, U = 362, z = -2.07, p = .04). 
Serum IL-2 concentrations were positively associated with vocal YGTSS ratings (r = 
.25, p = .05); serum IL-12 concentrations negatively with compulsive and total CYBOCS 
ratings (r = -.28, p = .03 and r = -.26, p = .04, respectively). None of the correlations met 
the stringent significance level after correction for multiple testing. No other 
statistically significant associations between serum concentrations of cytokines and 
soluble adhesion molecules and symptom severity ratings were present. 
Discussion 
The present study suggests that children and adolescents with a tic disorder do not 
differ from healthy volunteers with regard to serum levels of several cytokines and 
soluble adhesion molecules. However, we found a positive association between serum 
IL-2 concentrations and tic severity ratings, and an inverse relation between serum IL-
12 levels and severity of comorbid obsessive-compulsive symptoms, although these 
relations were not robust after corrections for multiple testing. 
Our results are in line with the study of Gabbay et al.
18
 who also did not find 
differences in plasma levels of TNF-α, IL-1β, IL-12, IL-6, and IL-2 between patients with 
TD and controls, but are in contrast with an earlier study
17
 that reported higher serum 
levels of IL-12 and TNF-α in children with TD and/or OCD compared to control subjects. 
The associations between IL-2 and tic severity, and IL-12 and OCD symptom severity, 
had not been identified in previous studies.
17,18
 Discrepancies between the studies may 
be due to different laboratory techniques and factors that may have influenced 
cytokine levels, for example stress and food intake. Furthermore, Leckman et al.
17
 had 
also included patients with OCD only, but not excluded subjects with immunological or 
infectious disorder. 
IL-2 and IL-12 are Th1 cytokines and as such mainly involved in cellular immune 
responses. Thereby, both cytokines contribute to the development of autoimmune 
responses. IL-2 plays an essential role in T cell activation and the differentiation of a 
subset of Tregs.
25,26
 Interestingly, given the involvement of the dopamine system in tic 
disorders, IL-2 may influence dopaminergic pathways.
27
 Although the relation between 
IL-2 and tic severity did not reach significance after multiple testing correction, the 
present finding weakly points to a role of cellular immune effector pathways in tic 
disorders. IL-12 induces IFN-γ production by Th1 and NK cells
28
, but also contributes to 
autoimmunity by restoring T cell activation and effector functions in the presence of 
Tregs
29
, and enhancing the affinity of cytotoxic T cells for peptides.
30
 Tregs that usually 
inhibit such responses may be deficient in patients with TD.
7
 Considering the 
enhancing effect of IL-12 on cellular immune and autoimmune responses, our finding 
of a negative relation between IL-12 and obsessive-compulsive symptoms in patients 
with tics, speaks against a role of these responses in comorbid OCD symptom severity. 
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The present study could also not confirm the earlier documented increased serum 
sVCAM-1 levels in children with TD.
21
 However, previous findings may have been due 




A number of limitations of this study need to be addressed. Although the use of a 
multi-cytokine array is appealing, the sensitivity to detect all cytokines simultaneously 
is often low. Indeed, an obvious limitation of our study is that a number of cytokines 
could not be detected in sizeable portions of patients and controls. However, 
frequencies of subjects with cytokines in the detectable range generally did not differ 
between patients and controls which speaks against major changes in these cytokine 
levels in patients. Another potential limitation is that 56% of patients used 
psychotropic medication which may have induced anti-inflammatory side-effects and 
also affected symptom severity. Finally, the control group was not gender-matched. 
Conclusions 
The present study does not reveal major immune activation in patients with a tic 
disorder. The possible association between serum IL-2 levels and tic severity ratings 
could indicate involvement of cellular immune effector pathways in the pathogenesis 
of tic disorders. However, the inverse relation between serum IL-12 concentrations 
and severity of comorbid OCD symptoms is difficult to explain. These findings are very 
preliminary and replication is warranted. To facilitate the search for 
immunopathogenetic mechanisms underlying tics, future studies should focus on more 
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Background Two epidemiological studies have suggested an increased frequency of 
infections in patients with a tic disorder, implying some form of immune deficiency. 
We investigated whether patients of two independent study samples have 
underlying altered immunoglobulin (Ig) profiles and whether Ig profiles change 
during tic exacerbations.  
Methods In the primary sample, consisting of 21 children and adolescents with a tic 
disorder and 21 healthy age-matched controls, we compared serum levels of IgG1, 
IgG2, IgG3, IgG4, IgM, and IgA. Those Ig levels that yielded between-group 
differences were subsequently compared between 53 patients and 53 healthy age-
matched subjects of the replication sample. We also investigated possible relations 
between Ig concentrations and tic severity ratings. Of 13 additional patients, we 
compared Ig concentrations between time points before, during, and after 
exacerbations of tics. 
Results IgG3 levels were significantly lower in patients compared to healthy children of 
the primary sample (medians 0.28 versus 0.49 mg/ml, p = .04), while levels of IgG2, 
IgG4, and IgM were decreased at trend-level (p ≤ .10). Decreased IgG3 (medians 
0.45 versus 0.52 mg/ml; p = .05) and IgM (medians 0.30 versus 0.38 mg/ml; p = .04) 
levels were confirmed in the replication sample. Ig levels did not correlate with tic 
severity. There was a trend to elevated IgG1 during symptom exacerbations (p = 
.09). 
Conclusion Children with a tic disorder had decreased serum IgG3 and IgM levels, 
which may be related to increased susceptibility to recurrent infections. Serum 




Tic disorders, such as Tourette’s disorder (TD), are neuropsychiatric conditions 
characterized by the presence of involuntary, rapid, recurrent, non-rhythmic 
movements, and/or vocalizations. Although the exact etiological mechanisms remain 
in doubt, both genetic and environmental factors have been demonstrated to 
contribute to the development of tics.
1
 
In 1998 Swedo and colleagues proposed a putative subgroup of neuropsychiatric 
disorders, designated as Pediatric Autoimmune Neuropsychiatric Disorders Associated 
with Streptococcal infections (PANDAS), characterized by the sudden onset and/or 
symptom exacerbations of obsessive-compulsive disorder (OCD) and/or tic disorder 
which are temporally related to group A ß-hemolytic streptococcal (GABHS) 
infections.
2
 Introduction of the concept of PANDAS has greatly fuelled research into 
the possible role of infections and (auto)immunity in tic disorders. Although the 
involvement of the immune system in tic disorders is still controversial
3,4
, indirect 
support has been provided by studies reporting on presence of antineuronal 
antibodies
5-7
, decreased numbers of regulatory T cells
8
, and increased single time point 
serum levels of antistreptococcal antibodies
9






Perhaps the most solid evidence in favor of a role for the immune system in tic 
disorders is formed by evidence suggesting that children with tics may be more 
vulnerable to infections. Two epidemiological studies have demonstrated that patients 
with newly diagnosed tic disorder or OCD were more likely to have had a GABHS 
infection in the previous year.
12,13
 Immunoglobulin (Ig) profiles may be an important 
factor related to susceptibility to infections. This is most evident in patients with Ig 
deficiencies who have consistently been shown to be vulnerable to recurrent 
infections.
14-16
 A recent study
17
 has compared plasma IgG and IgM levels of 59 children 
with autism, 25 healthy controls, and 24 patients with TD, but demonstrated no 
differences. In a preliminary report
18
, we also found no differences regarding plasma 
levels of IgG and IgM in patients with TD and/or OCD compared to healthy subjects, 
but IgA concentrations appeared to be decreased in patients. Moreover, patients 
fulfilling PANDAS criteria showed decreased IgA levels compared to non-PANDAS 
cases. 
In the present study, we compared serum levels of IgG subclasses IgG1, IgG2, IgG3, 
and IgG4, of IgM and IgA between children and adolescents with a tic disorder and 
healthy children. We also investigated possible relations of Ig levels with severity of 
tics. Finally, we made comparisons of serum Ig concentrations between time points 







The study involved two independent cross-sectional samples and one longitudinal 
sample. Table 1 shows demographic and clinical characteristics of the study samples. 
Cross-sectional samples. Our primary sample involved 21 pediatric patients who 
fulfilled Diagnostic and Statistical Manual of Mental Disorders fourth edition, text 
revised (DSM-IV-TR) criteria
19
 for a tic disorder and 21 individually age-matched 
healthy volunteers. Patients had been recruited through the Yale Child Study Center, 
New Haven, CT; healthy volunteers by the use of telemarketing lists of telephone 
numbers. Exclusion criteria included an intelligence quotient of <75, presence of a 
serious medical illness, major sensory handicaps (e.g., blindness, deafness), major 
neurological diseases (including a seizure disorder), head trauma resulting in loss of 
consciousness, or a current (past 6 months) psychiatric disorder that could interfere 
with participation, such as major depression, psychosis, or an autism spectrum 
disorder. Information concerning the patients, including assessment of PANDAS status, 
was collected in a two-stage process as previously described.
11
 
The replication sample consisted of 53 pediatric patients who fulfilled DSM-IV 
criteria for a tic disorder and 53 individually age-matched healthy volunteers. Patients 
had either been recruited through the Groningen University Child and Adolescent 
Psychiatry outpatient clinic in the Netherlands (n = 40) or through the Dutch TD 
Association (n = 13); healthy volunteers had been recruited through advertisements in 
local news papers. Patients were asked whether the onset or exacerbation of tics were 
temporarily associated with GABHS infections. Exclusion criteria were presence of an 
active infection, inflammation, atopic conditions, an autoimmune disorder, or autism. 
In both samples, tic severity was assessed by using the Yale Global Tic Severity 
Scale (YGTSS). This is a semi-structured interview which records the number, 
frequency, intensity, complexity, and interference of motor and vocal tics separately.
20
 
Longitudinal sample. Sera of 13 additional patients with a tic disorder were 
available before, during, and after an exacerbation of tics. These patients had been 
followed prospectively for periods ranging from 4 to 24 months at the Yale Child Study 
Center as part of a larger longitudinal study
11
, involving monthly clinical assessments 
and collection of serum specimens both at regular four-month intervals and in case of 
an exacerbation. An exacerbation of tics was defined as a total YGTSS score exceeding 
the previous monthly score by nine points and the total YGTSS score exceeding 19. 
Informed consent from parents and children of 12 years or older, and assent from 
children between 6 and 12 years had been obtained. The study had been approved by 





 Table 1 
Demographic and clinical characteristics of patients with a tic disorder and healthy subjects. 
 
Primary sample Replication sample 
Longitudinal 
sample 
n = 13 
 
Patients 
n = 21 
Healthy 
subjects 
n = 21 
Patients 
n = 53 
Healthy 
subjects 
n = 53 
 
  
Male, n (%) 17 (81.0) 13 (61.9) 45 (84.9) 22 (41.5) 9 (69.0)













 n (%) n (%) n (%)
Type of tic disorder  
Tourette’s disorder 18 (85.7) 52 (98.1) 12 (92.3)
Chronic motor tic disorder 3 (14.3) 1 (1.9) 1 (7.7)
  
Patients fulfilling PANDAS 
criteria 
3 (14.3) 0 5 (38.5)
  
Psychotropic medication   
Antipsychotic agents 1 (4.8) 9 (17.0) 0
Antidepressive agents 2 (9.5) 1 (1.9) 1 (7.7)
Clonidine 5 (23.8) 3 (5.7) 5 (3.8)
Psychostimulants 0 4 (7.5) 0
Atomoxetine 0 4 (7.5) 0
Combination of two or more 
agents 
8 (38.1) 12 (22.6) 6 (4.6)



































PANDAS, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections; 





Analysis of serum samples 
Ig concentrations were measured in archived sera using Luminex based Ig Isotyping 
reagent kit for measurement of IgG1, IgG2, IgG3, IgG4, IgM, and IgA (Bio-Rad 
Laboratories, Hercules, CA, catalog number 171-A3001M) in 10,000 fold diluted serum 
samples according to manufacturer’s instructions. Briefly, anti-isotype-conjugated 
beads were pipetted in a 96-well pre-wet filtration plate (Catalog number 
MSBVN1210) and incubated with 50 µl (10,000 times diluted) sample on a microplate 
shaker (IKA NTS 2/4 digital microtiter, catalog number 3208000) followed by three 
washes using multiscreen resist vacuum manifold (Millipore, Billerica, MA, catalog 
number MSVMHTS00). Then biotinylated detection antibody solution was added, 
incubated for 30 minutes on a microplate shaker, and washed three times. 
Subsequently, streptavidin-phycoerythrin was added and incubated for 10 minutes 
while shaking and then washed three times. The fluorescence signal was analyzed 
using a Bioplex 200 suspension array system (Bio-Rad Laboratories, Hercules, CA, 




In the primary cross-sectional sample, we made comparisons between patients and 
healthy subjects by using the Mann-Whitney test with regard to the measured serum 
Ig levels. We investigated possible relations between serum Ig concentrations, and 
mean total, vocal, and motor YGTSS ratings by using Spearman’s correlation 
coefficient. Those Ig levels that yielded at least trend-level statistically significant (i.e., 
p ≤ .10) between-group differences or correlations with tic severity were subsequently 
analyzed in the replication sample. 
Because gender ratios differed between patients and healthy children of the 
replication sample, we also made comparisons between male and female healthy 
children regarding serum Ig concentrations. As psychotropic medication may have 
induced immune alterations, we also compared patients with and without 
psychotropic medication use. 
With regard to the longitudinal sample, we made comparisons of serum Ig 
concentrations between time points before, during, and after an exacerbation of tics 
by conducting repeated-measures analysis of variance (ANOVA). If serum 
concentrations yielded at least trend-level statistically significant differences between 
time points, Bonferroni Post Hoc Analyses were performed.  
In all statistical analyses p ≤ .05 was considered as significant, and p ≤ .10 as trend-




 Table 2a 
 Serum Ig levels of patients with a tic disorder and healthy subjects of the primary 
sample. 
 
Serum Ig level  
Patients 
n = 21 
Healthy subjects 
n = 21 
   
(mg/ml) Median (p25/p75) Median (p25/p75) U z p 
IgG1 8.46 (6.14/13.1) 9.61 (8.18/13.8) 175 -1.15 .25 
IgG2 2.30 (1.07/3.69) 3.22 (2.05/6.24) 150 -1.79 .07 
IgG3 0.28 (0.18/0.64) 0.49 (0.37/0.61) 137 -2.10 .04 
IgG4 0.23 (0.09/0.48) 0.45 (0.17/0.63) 152 -1.72 .09 
IgM 0.34 (0.23/0.48) 0.42 (0.37/0.60) 149 -1.80 .07 
IgA 1.11 (0.70/1.98) 1.32 (0.96/1.79) 196 -0.62 .54 
Ig, immunoglobulin.       
 
Table 2b 
Serum Ig levels of patients with a tic disorder and healthy subjects of the replication 
sample. 
 
Serum Ig level  
Patients 
n = 53 
Healthy subjects 
n = 53 
   
(mg/ml) Median (p25/p75) Median (p25/p75) U z p 
IgG2 1.76 (1.12/2.75) 1.88 (1.13/3.34) 1313 -0.58 .56 
IgG3 0.45 (0.31/0.59) 0.52 (0.34/0.75) 1095 -1.96 .05 
IgG4 0.25 (0.14/0.54) 0.18 (0.06/0.32) 1038 -2.31 .02 




Serum Ig levels before, during, and after a tic exacerbation in 13 patients with a tic 
disorder. 
 







   
(mg/ml) Mean (SD) Mean (SD) Mean (SD) F df p 
IgG1 11.8 (3.29) 14.3 (3.79) 11.4 (5.88) 2.63 2, 24 .09
a
 
IgG2 2.82 (0.99) 3.48 (1.69) 3.07 (2.11) 1.09 2, 23 .35 
IgG3 0.65 (0.36) 0.79 (0.47) 0.65 (0.44) 2.94 2, 24 .17 
IgG4 0.39 (0.35) 0.42 (0.27) 0.35 (0.27) 0.93 2, 24 .41 
IgM 0.42 (0.20) 0.50 (0.24) 0.46 (0.32) 1.33 2, 24 .28 





Bonferroni Post Hoc test: mean difference between before and during exacerbation: -
2.56 (SE 1.0), p = .08; mean difference between during and after exacerbation: 2.88 (SE 1.5), p = .24. 
b
Bonferroni Post Hoc test: mean difference between before and during exacerbation: -0.40 (SE 0.2), p = 






Table 2a shows comparisons regarding serum Ig concentrations between patients and 
healthy subjects of the primary sample. Of note, median serum IgG3 concentrations 
were significantly lower, and median serum IgG2, IgG4, and IgM concentrations at 
trend-level significantly lower in patients compared to healthy subjects (figures 1 and 
2). No associations between serum Ig concentrations and YGTSS ratings were present. 
In the replication sample, median serum IgG3 and IgM concentrations were 
significantly lower in patients compared to healthy children (table 2b, figures 1 and 2). 
However, in contrast with the findings of the primary sample, median serum IgG4 
concentrations were significantly higher in patients. 
No gender differences regarding Ig levels in both samples were present, with the 
exception of serum IgM concentrations that were significantly lower in male healthy  
children compared to females (0.32 versus 0.40 mg/ml, U = 232, z = -1.97, p = .05) of 

























Figure 1. Serum IgG3 levels in children with a tic disorder and healthy subjects of the primary and 
replication samples. The bars represent the medians in each group. 
tic patients of the primary sample (n = 21)
healthy subjects of the primary sample (n = 21)
tic patients of the replication sample (n = 53)
healthy subjects of the replication sample (n = 53)
p = .05p = .04
Ig, immunoglobulin.
  
In the primary sample, no differences between patients with and without 
psychotropic medication use were present. Patients of the replication sample that 
used psychotropic medication, had only significantly lower serum levels of IgG4 
compared to patients without psychotropic medication use (respective medians 0.22 
mg/ml versus 0.32 mg/ml, U = 224, z = -1.95, p = .05). 
 
Longitudinal findings  
Table 3 shows serum Ig concentrations before, during, and after a tic exacerbation. Of 
note, mean serum IgG1 and IgA concentrations were at trend-level significantly 
elevated during exacerbation of tics. In Post Hoc analyses, the trend to an increase of 
IgA level during exacerbation did not remain present. However, the difference 
between IgG1 level during exacerbation and IgG1 level before, but not after, 























Figure 2. Serum IgM levels in children with a tic disorder and healthy subjects of the primary and
replication samples. The bars represent the medians in each group. 
tic patients of the primary sample (n = 21)
healthy subjects of the primary sample (n = 21)
tic patients of the replication sample (n = 53)
healthy subjects of the replication sample (n = 53)




The present study demonstrates lower IgG3 and IgM levels in children and adolescents 
with a tic disorder in comparison to age-matched healthy subjects in two independent 
patient-control comparisons. Tic severity ratings were not related to serum Ig 
concentrations. However, there was an overall tendency of increased Ig levels during 
exacerbations with IgG1 elevations actually approaching significance. 
The observed differences regarding IgG3 and IgM do not correspond to fully 
expressed deficiencies, defined as a decrease of two standard deviations below the  
mean of appropriate age. Clinical consequences of the observed changes may be 
extrapolated from the presentation of isolated IgG3 and IgM deficiencies with 
recurrent infections affecting mainly the upper respiratory tract.
14-16,21-24
 Since patients 
with a tic disorder may suffer more frequently from upper respiratory tract 
infections
13,14
, the decrease in IgG3 and IgM may be closely related to this 
susceptibility. Among all Ig subclasses, IgG3 and pentameric IgM are the most potent 
activators of the classical complement cascade that leads to the formation of 
membrane attack complexes and the destruction of microbial pathogens. Both IgG3 
and monomeric IgM play a role in phagocytosis.
25,26
 Because both IgG3 and IgM are 
involved in immune responses against a wide range of microorganisms
23,24,26-28
, the 
findings of lower IgG3 and IgM levels may indicate that the clearance of multiple 
microorganisms is compromised in patients with tic disorders. In agreement with this, 
common cold and Mycoplasma pneumonia have previously been related to tics.
29,30
 
In contrast with our finding of lower IgM levels in patients with tics, Libbey et al. 
have not reported differences between patients with TD and healthy controls.
17
 In our 
study, the decrease of serum IgM in patients with a tic disorder may have been 
confounded by gender, given the preponderance of male patients compared to the 
healthy subjects in the replication sample, and the fact that IgM levels of the healthy 
male subjects were significantly lower than those of the healthy female subjects. 
However, in the initial sample no gender differences regarding serum IgM 
concentrations were present while differences between patients and controls were 
similar as in the replication sample, altogether suggesting a true effect of clinical 
status. 
We could not replicate our previous preliminary findings of decreased IgA levels in 
patients with TD and/or OCD.
18
 We do not have a full explanation for this. However, 
the previous study has also included patients with OCD but no tics, possibly leading to 
a more heterogeneous study sample. Moreover, 39% of patients fulfilled PANDAS 
criteria and in these cases IgA levels were even further decreased. In the present study 
only three patients of the initial sample and none of the replication sample fulfilled 
PANDAS criteria. Clearly, more work is warranted with regard to comparisons between 
PANDAS and non-PANDAS cases. 
The tendency of increased Ig levels during exacerbations, mainly of IgG1, suggests 
that, at least in some patients, humoral immunity might be related to symptom 
7 
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 elicitation. No previous longitudinal studies regarding Igs in neuropsychiatric disorders 
have been performed. In a mouse model of PANDAS, mice immunized with GABHS-
immunization exhibited repetitive behavior that correlated with elevated anti-
neuronal IgG1 in their serum and the presence of immune deposits in brain tissue. 
Naive mice that received IgG from PANDAS mice also developed behavioral changes, 
and the depletion of IgG from donor sera abrogated the behavior changes.
31
 
A number of limitations need to be acknowledged. First, the sample sizes of the 
study groups have been relatively small especially with regard to the longitudinal 
sample. Because of the small sample sizes, we did not apply a multiple comparison 
correction, in order to preserve statistical power, but this may have increased the type 
I error rate. Second, the control group of the replication sample was not fully gender-
matched. Another disadvantage of our study has been the difference in exclusion 
criteria between the initial and replication sample. An important limitation is the use 
of psychotropic medication in 76% and 62% of the patients of the initial and replication 
sample, respectively, which may have induced anti-inflammatory side-effects and 
affected tic severity. Finally, we did not have any data on infection history of the 
subjects. It would be interesting in future longitudinal studies to directly investigate 
the possible impact of lowered Ig levels in children with a tic disorder on susceptibility 
to infections and possibly associated fluctuations in tic severity. 
Although the exact pathophysiological mechanisms remain unclear, the present 
study indicates that at least a subgroup of children with tic disorders may have a 
dysregulated immune system. The strongest evidence to support this are the lower 
IgM and IgG3 levels which were actually present in two independent samples. Future 
studies should address B cell function to identify whether this is due to decreased 
production, increased degradation, or increased binding of the Igs to a yet unknown 
site. The increased IgG1 levels during exacerbations of tics may provide additional 
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 Summary and general discussion 
Tic disorders are neuropsychiatric conditions characterized by the presence of rapid, 
recurrent, non-rhythmic movements, and/or vocalizations. Tics itself often cause no 
hinder. However, many patients suffer from comorbid (symptoms of) attention 
deficit/hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), 
internalizing disorders, or an autism spectrum disorder (ASD).
1
 The exact etiological 
mechanisms underlying tics and comorbid symptoms remain in doubt. Since in the 
1960s neuroleptic medication has proved to be efficacious in patients with a tic 
disorder, many researchers have started to investigate possible neurobiological 
pathways involved in tics.
2
 
It has been noticed for many years that tics run in families and a wealth of studies 
have established their genetic background.
3,4
 In the view of findings of 
pharmacological and biochemical studies in patients with tic disorders, genes encoding 
serotonergic and dopaminergic neurotransmission are of considerable interest.
5-7
 
However, no independently replicated genetic vulnerability regions have been 
identified yet. The unravelling of neurobiological pathways involved in tics may be 
hindered by the clinical heterogeneity of tic disorders and possible modulation of gene 
effects by environmental factors, such as perinatal adversities and infections. Perinatal 
adverse events have been found to be associated with tic disorders as well as 
comorbid OCD and ADHD, although results have been somewhat inconsistent.
8-12
 
Regarding the suggested involvement of the immune system in tic disorders
13
 some 





 leading to increased vulnerability to infections in 
patients with tics. 
The general aim of the studies described in this thesis was to examine the possible 
contribution of neurobiological factors to the development of tic disorders. 
Specifically, we have investigated possible relations between perinatal adversities and 
severity of tics and comorbid symptoms. Moreover, possible associations of 
polymorphisms located at dopaminergic and serotonergic genes with severity of tics 
and comorbid symptoms have been addressed, both separately as well as in 
interaction with perinatal adversities. Regarding the immune system we have studied 
possible immune disturbances and immunoglobulin (Ig) profiles in children and 
adolescents with a tic disorder. 
Perinatal adversities 
Chapters 2, 3, 4, and 5 describe our studies regarding perinatal adversities in patients 
with tics and comorbid symptoms of OCD, ADHD, internalizing disorders, and/or ASD. 
We assessed presence of pregnancy and delivery complications, and prenatal exposure 
to smoking. In the study we report on in chapter 2, we also assessed presence of 
8 
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postnatal complications and maternal alcohol use during pregnancy. Patients with and 
without these perinatal adversities were compared regarding the various symptom 
severity ratings. We have detected that children with tics who had been exposed to 
smoking during pregnancy had more severe ADHD, depressive, and autistic symptoms, 
but decreased tic severity; children with pregnancy complications had more severe 
tics, but decreased OCD symptom severity; children born after a complicated delivery 
had increased severity of tics and ADHD symptoms. In line with findings of previous 
studies
8-11
, the present results suggest that smoking exposure in utero may contribute 
to the severity of comorbid symptoms in children with tics, whereas pregnancy and 
delivery complications may mainly influence severity of tics and co-occurring ADHD 
and OCD features. The inverse relation between tic severity and prenatal smoking 
exposure is difficult to relate to earlier studies, and should be interpreted with caution. 
In 75 children and adolescents with a tic disorder, we have investigated by using 
linear regressions whether perinatal adversities would interact with presence of tic or 
any mental disorders in first-degree relatives with the tic or comorbid ADHD severity 
measure as outcome (chapter 2). We found evidence of an interaction between 
smoking exposure in utero and a positive family history of mental disorders regarding 
ADHD symptom severity: in patients with a first-degree relative with a mental disorder, 
smoking exposure during pregnancy was associated with a higher hyperactive-
impulsive score, whereas in patients without a first-degree relative with a mental 
disorder, prenatal smoking exposure was not associated with ADHD symptom severity. 
These findings suggest that gene-environment interactions may be involved in tics. 
Genetic factors and gene-environment interactions 
In chapters 3, 4, and 5 we present the findings of three molecular genetic studies that 
have addressed possible main effects of the 5-hydroxytryptamine transporter-linked 
polymorphic region (5HTTLPR) including rs25531, monoamine oxidase (MAO) A 
upstream variable number of tandem repeats (uVNTR), dopamine receptor (DR) D4 48 
base pairs (bp) VNTR, and three single nucleotide polymorphisms (SNP) located at the 
solute carrier family 6, member 3 gene (SLC6A3) regarding severity of tics and co-
occurring symptoms. Subsequently, through linear regressions we have examined 
whether these polymorphisms may interact with perinatal adversities to influence tic 
or comorbid symptom severity. 
The first study (chapter 3) has investigated possible relations of 5HTTLPR and the 
MAOA uVNTR with severity of tics and comorbid ADHD, OCD, and ASD symptoms. We 
genotyped 109 children and adolescents with a tic disorder and compared children 
with and without a 5HTTLPR long (L)A allele, and males with and without a MAOA 
uVNTR high-activity allele regarding severity of tics and comorbid symptoms. Presence 
of an LA allele was associated with increased severity of tics and comorbid ADHD, OCD, 
and ASD symptoms suggesting a shared genetic vulnerability located at 5HTTLPR 
underlying tics and a wide range of comorbid disorders. Presence of a MAOA uVNTR 
8 
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 high-activity allele was related to decreased ASD symptom severity which may point to 
a possible protective influence of MAOA regarding ASD symptoms in boys with a tic 
disorder. Intriguing, the relationship between delivery complications and tic severity 
appeared to be most pronounced in males without MAOA uVNTR high-activity allele: 
in the absence of a high-activity allele, delivery complications were associated with 
higher tic severity ratings, while in presence of a high-activity allele, delivery 
complications were not associated with tic severity. In conclusion, this study provides 
evidence for a contribution of 5HTTLPR and the MAOA uVNTR to severity of tics and 
comorbid features. Moreover, the MAOA polymorphism may interact with delivery 
complications to modulate tic severity. 
Chapter 4 documents the findings regarding relations between the DRD4 48-bp 
VNTR and severity of tics and comorbid obsessive-compulsive, depressive, anxious, and 
autistic symptoms. In 110 children and adolescents with tics we examined associations 
between the 2, 3, 4, and 7 repeat (R) alleles of the DRD4 48-bp VNTR and severity of 
tics and comorbid symptoms. The 2R allele appeared to be a genetic risk factor for 
OCD symptom severity, and the 3R allele for ASD symptom severity in children with a 
tic disorder. In children without a 3R allele delivery complications were associated with 
more severe tics, but in children with a 3R variant an inverse relation between delivery 
complications and tic severity was found. Moreover, the relation between delivery 
complications and internalizing symptom severity appeared to be most pronounced in 
children with a 2R allele. These data suggest that the 48-bp VNTR may influence 
severity of co-occurring OCD and ASD symptoms, and hints at interactions of the 48-bp 
VNTR with delivery complications regarding severity of tics and comorbid internalizing 
symptoms. 
Results regarding the SLC6A3 gene and severity of tics and comorbid OCD and 
ADHD features are described in chapter 5. In 132 patients with tics three SNP markers 
located at the 3’ and 5’ ends of SLC6A3 (rs40184, rs11564750, and rs2550946) were 
genotyped. Possible associations between alleles of the SNP markers and severity of 
tics and comorbid symptoms were addressed. Presence of an rs40184 G allele was 
associated with increased severity of inattentive symptoms. Moreover, pregnancy 
complications appeared to interact with rs11564750 and rs2550946 to decrease 
severity of comorbid obsessions and compulsions. This study provides preliminary 
evidence for a role of the SLC6A3 gene in the expression of comorbid inattentive 
symptoms and of gene-environment interactions between SLC6A3 and pregnancy 
complications regarding severity of obsessive-compulsive symptoms in patients with a 
tic disorder. 
In conclusion, the findings of our genetic molecular studies support the notion of 
serotonergic and dopaminergic genes being involved in the phenotypic expression of 
tic and comorbid disorders, and suggest that these genes may interact with perinatal 
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Immune system 
The other main topic of this thesis was the relation between tics and the immune 
system, in particular the presence of immune disturbances and alterations of Ig 
profiles in children and adolescents with a tic disorder. 
Chapter 6 reports on our findings regarding cytokines and soluble adhesion 
molecules in tic disorders. We compared serum levels of interleukin (IL)-2, IL-4, IL-5, IL-
10, IL-12, soluble IL-2 receptor (sIL2R), tumor necrosis factor (TNF)-α, interferon (IFN)-
γ, soluble vascular cell adhesion molecule-1 (sVCAM-1), and intercellular adhesion 
molecule-1 (sICAM-1) of 66 children and adolescents with a tic disorder and 71 healthy 
volunteers. We also investigated possible relations between concentrations of the 
immune markers and severity ratings of tics and comorbid obsessive-compulsive 
symptoms. Serum levels of the immune markers did not differ between patients and 
healthy children. Serum IL-2 concentrations were positively associated with tic severity 
which could indicate involvement of cellular immune effector pathways in tic 
disorders. However, serum IL-12 concentrations were negatively related to severity of 
comorbid obsessive-compulsive symptoms which is difficult to explain. In conclusion, 
these preliminary findings do not reveal major immune activation in children with a tic 
disorder, but replication is warranted. 
Chapter 7 contains the results of our study regarding Ig profiles (i.e., serum levels of 
IgG1, IgG2, IgG3, IgG4, IgM, and IgA) in children and adolescent with tics of two 
independent study samples as well as during tic exacerbations. In the primary sample, 
consisting of 21 children and adolescents with a tic disorder and 21 healthy age-
matched controls, serum IgG3 levels were significantly lower in patients while serum 
levels of IgG2, IgG4, and IgM were decreased at trend-level significance. Decreased 
serum IgG3 and IgM levels in patients were confirmed in the replication sample 
comprising 53 patients and 53 healthy age-matched subjects. In 13 additional patients, 
we compared Ig concentrations between time points before, during, and after 
exacerbations of tics and found a trend toward elevated IgG1 during tic exacerbations. 
These findings suggest that children with a tic disorder may have changed Ig profiles, 
comprising decreased serum IgG3 and IgM levels that may be related to increased 
susceptibility to recurrent infections. The finding of elevated serum IgG1 levels during 
tic exacerbations would be strengthened by independent replication. 
Future perspectives 
Considering the results described in this thesis, future studies should further explore 
the role of perinatal, genetic, and immunological factors in tic disorders. First, 
replication of the results described in this thesis is warranted in larger study samples 
that take into account clinical phenotype, including comorbidities, and psychotropic 
medication use. Large scale, multi-center, prospective studies are preferred. Following 
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 children at risk for a tic disorder (i.e., having a parent or sibling with tics) from 
pregnancy till adulthood may provide insight into the contribution of perinatal and 
immunological factors in genetically susceptible children. Moreover, cellular-molecular 
studies are needed. For example, considering the relations between perinatal 
adversities and tic and comorbid disorders, it is worthwhile to perform studies aimed 
at unravelling the exact pathophysiological pathways. Thereby, since the functional 
significances of the genetic polymorphisms studied in this thesis are still under debate, 
studies on this topic are warranted. With regard to our findings of lower Ig levels, it 
would be interesting to study the pathophysiological mechanisms leading to these 
lower levels in children with tics. While genes and environmental influences may 
interact and therefore complicate the search for neurobiological factors involved in tic 
disorders, future studies should take these interactions into account. 
Concluding remarks 
Although neurobiological factors have been suggested to contribute to the 
pathogenesis of tic disorders, the exact mechanisms so far have remained elusive. This 
thesis describes associations of tic disorders with perinatal adversities, serotonergic 
and dopaminergic genes, and immunological factors. Future research directed at 
replication of our findings and investigation of the underlying pathophysiological 
mechanisms is warranted. Interactions between genes and environmental factors may 
be a fruitful research area. To facilitate the unravelling of neurobiological pathways 
involved in tics, the phenotypic expression of tic disorders and comorbid symptoms 
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 Samenvatting in het Nederlands 
Tic-stoornissen zijn neuropsychiatrische aandoeningen die gekenmerkt worden door 
herhaald optredende, niet-ritmische bewegingen en geluiden, zogenaamde 
motorische en vocale tics. In de meeste gevallen leiden tics niet tot beperkingen. 
Echter, een groot deel van patiënten met tics heeft ook last van (symptomen van) 
aandachtstekortstoornis met hyperactiviteit (ADHD), obsessieve-compulsieve stoornis 
(OCD), internaliserende stoornissen en/of een autisme spectrumstoornis (ASD). Het is 
nog onduidelijk waardoor tics en deze bijkomende symptomen ontstaan. Sinds de 
ontdekking in de jaren zestig dat patiënten met een tic-stoornis baat kunnen hebben 
bij het gebruik van neuroleptica, is er veel onderzoek verricht naar mogelijke 
neurobiologische factoren die zouden kunnen bijdragen aan de ontwikkeling van tics. 
Ondanks dat genetische factoren ontegenzeggelijk een rol spelen, is nog niet 
duidelijk welke genen leiden tot een verhoogde kwetsbaarheid voor tic-stoornissen. 
Omdat farmacologische en biochemische studies erop wijzen dat de neurotransmitters 
serotonine en dopamine betrokken zijn, is het zinvol om serotonerge en dopaminerge 
genen te bestuderen bij patiënten met tics. De zoektocht naar genen wordt mogelijk 
bemoeilijkt door het bestaan van gen-omgevingsinteracties waarbij omgevingsfactoren 
die van belang kunnen zijn bij tics, zoals perinatale en immunologische factoren, 
geneffecten moduleren. Er zijn aanwijzingen dat complicaties tijdens de zwangerschap 
en bevalling een rol spelen bij tic-stoornissen en comorbide OCD en ADHD. Wat betreft 
het afweersysteem wordt gesuggereerd dat patiënten met tics een veranderde 
(cellulaire) afweer en/of een verminderde humorale immuniteit met als gevolg een 
verhoogde vatbaarheid voor infecties zouden kunnen hebben. 
Het doel van dit proefschrift is om de rol van genetische en omgevingsfactoren in 
tic- en comorbide stoornissen te verhelderen. In het bijzonder hebben polymorfismen 
van een aantal dopaminerge en serotonerge genen, perinatale omstandigheden en 
immunologische factoren onze interesse. 
Perinatale factoren 
In de studies beschreven in de hoofdstukken 2, 3, 4 en 5 hebben we de perinatale 
omstandigheden, te weten de aanwezigheid van zwangerschaps- en 
bevallingscomplicaties en prenatale blootstelling aan roken, van patiënten met een tic-
stoornis in kaart gebracht. In hoofdstuk 2 wordt ook gerapporteerd over postnatale 
complicaties en alcoholgebruik tijdens de zwangerschap. Patiënten met en zonder 
deze perinatale factoren werden vergeleken wat betreft de ernst van tics en 
comorbide symptomen van OCD, ADHD, internaliserende stoornissen en ASD. 
Zwangerschapcomplicaties bleken verband te houden met ernstigere tics, maar 




gecompliceerde bevalling hadden hogere tic- en ADHD-symptoomscores. Patiënten 
van wie de moeder rookte tijdens de zwangerschap hadden ernstigere ADHD-, 
depressieve en autistische symptomen, maar minder ernstige tics. Blijkbaar speelt het 
in de baarmoeder blootgesteld worden aan roken een rol in de expressie van 
comorbide symptomen, en zwangerschaps- en bevallingscomplicaties in de ernst van 
tics en van symptomen van OCD en ADHD. 
Vervolgens vonden we (hoofdstuk 2) in een groep van 75 kinderen en adolescenten 
met een tic-stoornis aanwijzingen dat een interactie tussen blootstelling aan roken 
tijdens de zwangerschap en een positieve familie-anamnese van psychische 
aandoeningen mogelijk van belang is voor de ernst van ADHD-symptomen: alleen in de 
groep patiënten met een eerstegraads familielid met psychische stoornissen leidde 
prenatale blootstelling aan roken tot hogere hyperactieve-impulsieve 
symptoomscores. Deze bevinding wijst indirect op een rol van gen-
omgevingsinteracties in tic- en comorbide stoornissen. 
Genetische factoren en gen-omgevingsinteracties 
In de hoofdstukken 3, 4 en 5 beschrijven wij de resultaten van drie studies naar een 
mogelijke betrokkenheid van serotonerge en dopaminerge genen bij tic-stoornissen. 
We hebben gezocht naar invloeden van 5HTTLPR (5-hydroxytryptamine transporter-
linked polymorphic region), MAOA uVNTR (monoamine oxidase A upstream variable 
number of tandem repeats), DRD4 48-bp (dopamine receptor D4 gen 48 base paren) 
VNTR, en drie SNP-markers (single nucleotide polymorphisms) van het SLC6A3-gen 
(solute carrier family 6, member 3) op de ernst van tics en comorbide symptomen van 
ADHD, OCD, internaliserende stoornissen en ASD. Daarna hebben we middels lineaire 
regressies bestudeerd of deze polymorfismen in interactie met perinatale factoren (te 
weten roken tijdens de zwangerschap, zwangerschaps- en bevallingscomplicaties) 
gerelateerd zijn aan de ernst van tics of comorbide symptomen. 
De eerste studie (hoofdstuk 3) rapporteert relaties tussen het 5HTTLPR lange (L)A 
allel en ernstigere tics en comorbide ADHD-, OCD- en ASD-symptomen, en tussen 
MAOA uVNTR hoog-activiteitsallelen en minder ernstige ASD-kenmerken in een groep 
van 109 kinderen en adolescenten met een tic-stoornis. Daarnaast bleek dat in 
afwezigheid, maar niet in aanwezigheid, van een MAOA uVNTR hoog-activiteitsallel 
bevallingscomplicaties gerelateerd waren aan ernstigere tics. Deze studie wijst erop 
dat 5HTTLPR en de MAOA uVNTR en een interactie tussen MAOA en 
bevallingscomplicaties mogelijk bijdragen aan de expressie van tics en comorbide 
kenmerken bij kinderen met een tic-stoornis. 
Hoofdstuk 4 beschrijft ons onderzoek in een groep van 110 kinderen en 
adolescenten met tics naar de 2-repeats (R), 3R-, 4R- en 7R-allelen van de DRD4 48-bp 
VNTR in relatie tot de ernst van tics en comorbide obsessieve-compulsieve, 
internaliserende en autistische symptomen. Aanwezigheid van een 2R-allel bleek 
gerelateerd aan ernstigere dwanggedachten en -handelingen, en van een 3R-allel aan 
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 ernstigere autistische kenmerken. Bij kinderen zonder 3R-allel vonden we een relatie 
tussen bevallingscomplicaties en ernstigere tics, terwijl in aanwezigheid van een 3R-
allel bevallingscomplicaties gerelateerd waren aan lagere tic-scores. Daarbij waren 
bevallingscomplicaties en internaliserende symptoomscores slechts met elkaar 
gerelateerd als er een 2R-allel aanwezig was. Kortom, deze studie suggereert dat de 
48-bp VNTR de ernst van comorbide symptomen bij kinderen met tics beïnvloedt, en 
dat de interactie tussen de 48-bp VNTR en bevallingscomplicaties mogelijk een rol 
speelt in de ernst van tics en internaliserende symptomen. 
Voor de laatste genetische studie (hoofdstuk 5) werden bij 132 patiënten met een 
tic-stoornis drie SNP-markers, die gelokaliseerd zijn in de 3’ en 5’ regio’s van SLC6A3 
(rs40184, rs11564750 en rs2550946), gegenotypeerd. We onderzochten mogelijke 
associaties tussen de allelen van deze SNP’s en de ernst van tics en comorbide OCD- en 
ADHD-symptomen. In aanwezigheid van een rs40184 G-allel waren comorbide 
concentratieproblemen ernstiger. Tevens vonden we aanwijzingen dat interacties 
tussen zwangerschapscomplicaties en zowel rs11564750 als rs2550946 een rol spelen 
in het verminderen van de ernst van dwanggedachten en –handelingen. SLC6A3 heeft 
dus mogelijk een aandeel in de expressie van comorbide ADHD-kenmerken en 
moduleert de relatie tussen zwangerschapscomplicaties en ernst van OCD-symptomen 
bij patiënten met een tic-stoornis. 
De bevindingen van de drie moleculair–genetische studies wijzen erop dat 
serotonerge en dopaminerge genen waarschijnlijk betrokken zijn bij de fenotypische 
expressie van tics en comorbide symptomen. Tevens hebben interacties tussen deze 
genen en perinatale factoren mogelijk een aandeel. Omdat onze onderzoeksgroepen 
relatief klein waren, moeten onze resultaten met de nodige voorzichtigheid worden 
geïnterpreteerd. Daarnaast is van groot belang dat onderliggende pathofysiologische 
mechanismen verder opgehelderd worden. 
Immunologische factoren 
In de hoofdstukken 6 en 7 staan de bevindingen van twee immunologische studies 
beschreven. In de eerste studie hebben we gekeken naar algemene immuunmarkers, 
namelijk cytokines en oplosbare adhesiemoleculen. Bij 66 kinderen en adolescenten 
met een tic-stoornis en 71 gezonde vrijwilligers hebben we serumconcentraties van 
interleukine (IL)-2, IL-4, IL-5, IL-10, IL-12, oplosbare IL-2 receptor (sIL2R), tumor 
necrosis factor (TNF)-α, interferon (IFN)-γ, oplosbare vasculaire cel-adhesiemolecuul-1 
(sVCAM-1) en intercellulaire adhesiemolecuul-1 (sICAM-1) vergeleken en onderzocht 
of er relaties zijn tussen serumconcentraties van deze immuunmarkers en ernst van 
tics en comorbide OCD-symptomen. Serumconcentraties van de immuunmarkers 
verschilden niet tussen patiënten en controles. Serumconcentraties van IL-2 bleken 
positief geassocieerd met tic-ernst, serumconcentraties van IL-12 negatief met ernst 
van obsessies en compulsies. De resultaten van deze studie wijzen niet op een 




tussen IL-2 en de ernst van de tics zou de cellulaire afweer een bijdrage kunnen 
leveren aan de fenotypische expressie van tics. 
Naast de hypothese dat infecties leiden tot tics laat een recente studie zien dat 
patiënten met tics mogelijk gevoeliger zijn voor infecties, hetgeen veroorzaakt kan 
worden door afwijkende antistofprofielen. Antistoffen worden ook wel 
immunoglobulines (Ig) genoemd. Er zijn verschillende subklassen die aangeduid 
worden met letters, en bij een nog verdere onderverdeling met cijfers, zoals IgA, IgM, 
IgG, IgG1, IgG2, IgG3 en IgG4. In hoofdstuk 7 beschrijven wij ons onderzoek naar Ig-
profielen (serumconcentraties van IgG1, IgG2, IgG3, IgG4, IgM en IgA) en tic-
stoornissen. Allereerst vergeleken wij in twee onafhankelijke studiegroepen de serum 
Ig-concentraties van kinderen en adolescenten met tics en gezonde vrijwilligers. In de 
primaire studiegroep waren de serum IgG3-concentraties van de 21 patiënten 
significant lager dan van de 21 gezonde kinderen, terwijl IgG2-, IgG4- en IgM-
concentraties een trend tot lagere waarden in de patiëntengroep lieten zien. Ook in de 
replicatiegroep waren de IgG3- en IgM-serumwaarden van de 53 patiënten verlaagd in 
vergelijking met de 53 gezonde controles. Daarna onderzochten we in een 
afzonderlijke groep van 13 patiënten Ig-concentraties voor, tijdens en na een 
exacerbatie van tics. Tijdens exacerbaties was er een trend tot verhoging van IgG1-
waarden. Kennelijk hebben kinderen met een tic-stoornis lagere serumconcentraties 
van IgG3 en IgM, hetgeen zou kunnen leiden tot een verhoogde kwetsbaarheid voor 
infecties. Het is zinvol om, gezien de verhoogde serumconcentraties van IgG1 tijdens 
exacerbaties van tics, een vergelijkbare studie in een grotere patiëntengroep te 
verrichten. 
Conclusie 
Hoewel er veel aanwijzingen zijn dat tic-stoornissen een neurobiologische basis 
hebben, blijven de exacte mechanismen onduidelijk. Dit proefschrift heeft associaties 
van tics met perinatale factoren, serotonerge en dopaminerge genen en 
immunologische factoren beschreven. Toekomstige studies, die deze bevindingen 
repliceren en de onderliggende pathofysiologische mechanismen ophelderen, zijn 
nodig. Daarnaast is verder onderzoek naar gen-omgevingsinteracties zinvol. Om het 
ontrafelen van bij tic-stoornissen betrokken neurobiologische factoren te 
vergemakkelijken, zou er meer aandacht moeten komen voor de fenotypische 





"Vroeger dacht ik dat mijn beperkingen mijn grenzen waren." (Loesje) 
 
Veel lieve, inspirerende en wijze mensen hebben mij gemotiveerd om over mijn 
"beperkingen" heen te kijken, grenzen te verleggen en een prestatie te leveren die ik 
niet voor mezelf weggelegd zag: het schrijven van een proefschrift. Ik wil graag 
degenen die mij hierbij hebben gesteund, bedanken. 
De omslag van dit proefschrift is een ode aan de kinderen en jongeren die mij 
geïnspireerd en gemotiveerd hebben om dit promotie-onderzoek te verrichten: 
kinderen in mijn directe omgeving, maar vooral de ruim 160 dappere jongens en 
meisjes bij wie ik bloed en een niet te onderschatten vragenlijstpakket mocht 
afnemen. Jongelui met tics, die zo graag willen weten waarom ze tics hebben; jongelui 
zonder tics, die solidair zijn met leeftijdgenoten die last hebben van tics. Ik heb mij 
verbaasd over de inzet van al deze kinderen en hun ouders. Duizendmaal dank voor 
jullie bijdrage en wijze lessen! 
Zonder promotores geen promotie. Twee bijzonder vriendelijke, enthousiaste 
hoogleraren hebben mij de afgelopen jaren bijgestaan. Ruud Minderaa bood mij de 
mogelijkheid om poliklinisch werk te combineren met promotie-onderzoek. Zijn deur 
stond altijd open, en zelfs toen ik besloot dat mijn toekomst niet in de psychiatrie lag, 
had hij bemoedigende, ondersteunende woorden voor me. Ik had het voorrecht Cees 
Kallenberg als tweede promotor te hebben omdat het de bedoeling was dat dit 
proefschrift vooral immunologische studies zou gaan bevatten. Vrijwel alles liep de 
afgelopen jaren anders dan gedacht, en mijn aandachtsgebied verschoof naar de 
genetica. Desondanks bleef Cees steeds betrokken en enthousiast. Ik waardeer de 
inspirerende, coachende en kritische gesprekken die we gevoerd hebben. 
Van onschatbare waarde is de samenwerking met Pieter Hoekstra, mijn 
copromotor, geweest. Mijn onderzoek was een voortzetting op zijn proefschrift. Toen 
de immunologie niet genoeg leek op te leveren voor een proefschrift, kwam hij al 
gauw met nieuwe onderzoeksideeën. Zijn inspanningen, creativiteit en vermogen om 
nieuwe onderzoeksprojecten te ontwikkelen en samenwerkingsverbanden tot stand te 
brengen, hebben me regelmatig verwonderd. Naast zijn professionele vaardigheden is 
Pieter ook erg aardig, laagdrempelig, belangstellend, scherpzinnig, humoristisch en 
mogelijk een tikje chaotisch. Ik heb geboft met en veel geleerd van onze 
samenwerking. 
Prof. dr. Jan Buitelaar, prof. dr. Piet Limburg en prof. dr. Tineke Oldehinkel wil ik 
bedanken voor hun bereidheid om deel uit te maken van de beoordelingscommissie. 
Piet was tevens nauw (en kritisch!) betrokken bij de opzet en uitvoering van de 
immunologische analyses. Na het eerste brainstormen kwam ik al gauw in contact met 
Johan Bijzet, die de eerste analyses uitvoerde en mij zelfs begeleidde op een tripje naar 




Samenwerken met hen is erg plezierig en ontspannen. Helaas is er in dit boekje weinig 
terug te vinden van al het werk dat door hen, met hulp van hun collega's, verricht is. 
Juist daarom, een extra applaus voor het lab! 
Mijn eerste onderzoeksjaar had ik geen idee van het bestaan van andere 
onderzoekers. Dat veranderde toen ik werd verhuisd naar de "onderzoeksgang" waar 
alle deuren altijd open staan en die een flink aantal inspirerende, talentvolle, 
vriendelijke mensen bleek te herbergen. Om een paar te noemen: Annelies de Bildt, 
Agnes Brunnekreef, Barbara van den Hoofdakker, Catharina Hartman, Harma Moorlag, 
Liza Muskee, Marjan Houwing, Myriam Harfterkamp, Neeltje Valkhof: stuk voor stuk 
mensen van wie ik geleerd en genoten heb. In het bijzonder heb ik geboft met ons 
"AIO-clubje": Christina Mathyssek: kort maar krachtig heb ik haar leren kennen, zelden 
zie je mensen met zoveel power, inzet en ambitie; Esther Sportel: alomtegenwoordig, 
vol optimisme, gezelligheid en betrokkenheid; Judith Nijmeijer, mijn lieve (LAT-) 
kamergenoot, heeft mijn lief en leed de afgelopen jaren gedeeld, en mij, als ik weer 
eens bedacht had om toch maar te stoppen, gemotiveerd om door te gaan. Ik gun haar 
haar boekje enorm; Julie Karsten: erg attent, betrokken en vrijgevig, ze trakteert 's 
maandags omdat het maandag is!; Sanne Kuijper: een gezellige, optimistische 
doorzetter en heerlijk mens, met altijd een hartelijk woord paraat; Yvonne Groen: 
gedreven, enthousiaste medemoeder en binnenkort prof (?!); Vera Dekker: vriendelijk, 
ontspannen en gezellig, een aanwinst voor het clubje! Zonder deze dames was ik vast 
een holbewoner geworden: dank voor de inspiratie, ontspanning, afleiding en hulp. 
Een aantal collega's heeft mij bijgestaan in de verschillende onderzoeksfasen. 
Allereerst mijn supervisoren van het eerste uur: Wies Buhre en Catrien Reichart. Toen 
ik me afvroeg of ik genoeg hersens zou hebben voor een promotietraject, waren zij 
alleen maar enthousiast en vol vertrouwen waardoor ik de uitdaging durfde aan te 
gaan. De eerste jaren vormden Pieter, Jetty Noltes en Wilma Kamp met mij het 
expertiseteam tic-stoornissen. Samen gingen we (drie dagen voor het begin van mijn 
zwangerschapsverlof!) naar Utrecht om een groep kinderen te zien voor het 
onderzoek. Veel van wat ik nu weet over tics heb ik van deze drie mensen geleerd, in 
het bijzonder van Jetty die mijn poliklinische werk superviseerde. Naast dat zij een 
wijze psychiater en topsupervisor is, is zij ook een boeiend en prachtig mens. Mascha 
van den Akker nam de (mijns inziens gruwelijke) klus op zich om alle vragenlijsten in te 
scannen en verzorgde alle logistiek omtrent de iDISC-vragenlijst. Ik weet niet meer 
waarvoor ik Mark-Peter wel en niet mag bedanken, maar ben erg dankbaar voor al zijn 
hulp en advies. Onverwachts kreeg ik hulp van een enthousiaste, nauwkeurige en 
ontzettend aardige studente, Anne Kuin, die haar wetenschappelijke stage wilde 
besteden aan het in kaart brengen van de perinatale gegevens van onze 
patiëntengroep. Anne heeft heel wat uurtjes tussen oude dossiers op een stoffige 
zolder gezeten. Door deze inspanning kwamen er zoveel nieuwe mogelijkheden dat ik 
weer begon te geloven in de haalbaarheid van een proefschrift. Ik ben de Stichting 
Gilles de la Tourette zeer erkentelijk voor het werven van een deel van de kinderen. 
Vermeldenswaardig is de samenwerking met middelbare scholiere Diede, die op eigen 
initiatief 30 jongelui rekruteerde om bloed te geven voor het onderzoek! Door de 
8 
113 
 samenwerking met Ivana Kawikova van Yale University kwam de immunoglobuline-
studie tot stand. I have never met Ivana face to face, but our working together was an 
intense and valuable experience. Ivana introduced to me a new point of view regarding 
tics and infections, and initiated, planned and performed the immunoglobulin 
analyses. It was a privilege to have worked with her, Renske Olieman and Zuzanna 
Tobiasova. 
In een drukke, hectische tijd als de afgelopen jaren is een liefdevolle thuishaven 
onontbeerlijk. Vooral het laatste jaar heb ik mijn familie en vrienden schandelijk 
verwaarloosd, maar steeds heb ik me gesteund gevoeld. Ik zie ernaar uit meer tijd met 
hen door te brengen. Zonder de anderen te tekort te doen, wil ik een paar naasten in 
het bijzonder noemen. Mijn moeder is uniek in haar soort. Mijn hele school-, studie- en 
werkcarrière stond zij aan de zijlijn te juichen. Bij alle pieken en dalen lag er een 
kaartje in de brievenbus. Zonder haar was ik niet geworden die ik ben. Mijn vader is 
eveneens niet te evenaren. Wat wij gepresteerd hebben de afgelopen twee jaar 
overstijgt elke andere prestatie. Wat ben ik dankbaar dat ik hem nu kan zien stralen 
van trots. Mijn schoonouders zijn van het "nait soezen, deurbroezen", en ik leer 
dagelijks van ze. Lievere mensen zijn er niet, ze staan werkelijk altijd voor ons klaar. 
Mijn broer Adry wil ik danken voor zijn bereidheid mijn altijd bereikbare (helemaal 
anno 2010), persoonlijke helpdesk te zijn. Tot slot: logistieke ondersteuning van het 
gezin is een must voor ouders om hun werk goed te kunnen doen. Mijn grote dank 
gaat vooral uit naar Alex en Kirsten, Jolanda, Klazina, mama en Henk, pa en ma. 
De mooiste promotie van de afgelopen jaren was mijn promotie tot moeder van 
twee wonderbaarlijke mensjes. Gijs en Katy hebben mij geleerd wat een 
moederinstinct is, en daardoor hebben ze me meer dan eens doen twijfelen aan de 
juistheid van mijn keuze een werkende, promoverende moeder te zijn. Toch gaven 
juist zij mij ook de motivatie om af te maken waar ik aan begonnen was. Ze zijn mijn 
alles. 
Het is een mirakel dat tijdens alle stress, klaagzangen, gemopper en getier er 
steeds één was die volkomen rustig, domweg in mij bleef geloven en in elke 
onderzoeksfase met me meedacht. Gaaijo, de liefde van mijn leven, heeft de 
afgelopen vijf jaar een heleboel met me beleefd. De komende vijf jaren worden vast 
niet rustiger. In this crazy life we lead, it's you I need…… 
De dag van mijn promotie wordt nog mooier door de aanwezigheid van mijn twee 
paranimfen. Carly, mijn lieve, mooie en niet eens zo hele kleine zusje, kwam 
halverwege dit promotietraject mijn leven binnenwandelen. Het is een feest om haar 
om je heen te hebben, en wat ben ik blij dat zij mijn paranimf wilde zijn. Inge leerde ik 
kennen als arts-assistent kindergeneeskunde. We kozen andere werkrichtingen maar 
de vriendschap werd hechter. Nu is de tijd gekomen dat ik haar gelijk moet geven: ik 
moet huisarts worden. 
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